WO2015167050A1 - Barrier membrane for implant - Google Patents

Barrier membrane for implant Download PDF

Info

Publication number
WO2015167050A1
WO2015167050A1 PCT/KR2014/003889 KR2014003889W WO2015167050A1 WO 2015167050 A1 WO2015167050 A1 WO 2015167050A1 KR 2014003889 W KR2014003889 W KR 2014003889W WO 2015167050 A1 WO2015167050 A1 WO 2015167050A1
Authority
WO
WIPO (PCT)
Prior art keywords
implant
bone
body portion
shield
graft material
Prior art date
Application number
PCT/KR2014/003889
Other languages
French (fr)
Korean (ko)
Inventor
김기수
정진영
Original Assignee
주식회사 이덴테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 이덴테크 filed Critical 주식회사 이덴테크
Priority to PCT/KR2014/003889 priority Critical patent/WO2015167050A1/en
Priority to CN201480078246.9A priority patent/CN106232051A/en
Publication of WO2015167050A1 publication Critical patent/WO2015167050A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/008Healing caps or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C5/00Filling or capping teeth
    • A61C5/007Dental splints; teeth or jaw immobilisation devices; stabilizing retainers bonded to teeth after orthodontic treatments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools

Definitions

  • the present invention relates to a shielding film, and more particularly to a shielding film for implants.
  • the dental implant procedure is generally completed by dissecting the patient's gums and inserting an implant post into the gum bone (called 'alveolar bone') therein, and joining an artificial tooth (Crown) to the implant post.
  • the alveolar bone in which the fixture is placed needs sufficient length and width. Bones are often absorbed or lost by other tissues. In this case, bone guidance regeneration (also called 'bone regeneration') is required. Unlike other tissues, bone has the only potential to fully recover the body's structure. However, a basic condition is required for bones to regenerate in the correct form: mechanical stability and abundant blood supply.
  • Biological requirements for bone induction regeneration include blood supply, stabilization, osteoblasts, limited space, space retention, and incisional wounds. Several surgical procedures are performed for this purpose. Providing proper pressure on the bone graft can increase adhesion and help bone formation.
  • shielding membranes are used for stabilization and limited space.
  • the shield helps protect blood clots, prevents soft tissue cells from migrating to bone defects, and allows bone cells to settle.
  • Embodiments of the present invention to stably support the bone graft material to provide an implantable shield membrane that can be performed to guide bone regeneration.
  • the implant membrane comprising an implant post coupled to the alveolar bone and a body portion covering the bone graft material added for induction of bone regeneration around the alveolar bone, the body portion for implants formed of bone components
  • a shielding film can be provided.
  • the body portion may include at least one bent portion formed to be bent to one side.
  • the body portion formed of the bone component may be a heterologous bone or synthetic bone.
  • the body portion may be formed by cutting the distal bone.
  • a space is formed inside the body portion, and may be installed so that at least one of the implant post and the bone graft material is inserted through the opening of the space.
  • the implant shield may further include a protrusion formed to protrude from the body portion.
  • the body portion and the protrusion may be formed of different materials.
  • the protrusion may be formed of at least one of a metal material and a plastic material.
  • the protruding portion may be tightly coupled to a concave portion formed on the upper surface of the temporary bolt fastened to the female coupling portion or the crown coupling female screw portion formed on the upper surface of the implant post.
  • the implant shield is formed of the bone graft material, and may further include a pad portion attached to the body portion in the form of a pad.
  • the body portion may be formed through the through-holes.
  • the plurality of through holes are provided, the plurality of through holes may be different from each other in diameter.
  • the through hole may be formed only in a portion of the body portion.
  • the body part may include a fixing member coupling part to which at least one of the alveolar bone and the bone graft material and a fixing member fixing the body part are coupled.
  • at least one surface of the body portion may be formed as a curved surface having a radius of curvature corresponding to the teeth.
  • Embodiments of the present invention can be easily absorbed by the bone graft material after the bone regeneration guided by the bone component, as well as to secure the bone regeneration space by stably supporting the bone graft below.
  • FIG. 1 is a schematic diagram showing that the dental implant device is implanted
  • Figure 2 is a cross-sectional view showing the cross-sectional view of the external dental implant device and internal dental implant device
  • Figure 3 is a shield for the implant covering the bone graft material
  • Figure 4 is a perspective view showing an implant shield according to an embodiment of the present invention
  • Figure 5 is a perspective view showing a distal bone formed with the implant shield is shown in Figure 4
  • Figure 6 is a (a ) Is a cross-sectional view showing a portion of the implant membrane and the implant post procedure is applied
  • Figure 7 is a cross-sectional view showing a portion for the implant membrane and implant post procedure shown in Figure 4 (b)
  • Figure 8 is a view of the present invention
  • 9 is a perspective view showing a shield for an implant according to another embodiment
  • FIG. 9 shows a shield for an implant according to another embodiment of the present invention.
  • 10 is a perspective view showing an implant shield according to another embodiment of the present invention
  • FIG. 11 is a perspective view of an implant shield according to another embodiment of the present invention
  • FIG. 12 is a line AA and BB of FIG. 13 is a perspective view of an implant shield according to another embodiment of the present invention
  • FIG. 14 is a perspective view of an implant shield according to another embodiment of the present invention
  • FIG. 15 is another embodiment of the present invention.
  • FIG. 16 is a plan view illustrating a shape of a through hole of an implant shield membrane according to an embodiment of the present invention.
  • a dental implant device generally refers to an artificial dental structure formed by implanting a fixture, which is an artificial tooth root, at a part or a whole where a tooth is lost, thereby adhering it to the alveolar bone, and fixing the dental prosthesis to the artificial tooth root.
  • the term implant can be used broadly to encompass such a concept as a dental procedure and can be used as narrowly as a fixture.
  • the implant or implant structure may be mainly used as a general artificial tooth structure.
  • 1 is a schematic diagram showing that the dental implant mechanism is placed.
  • 2 is a cross-sectional view showing a cross section of the implant mechanism.
  • the dental implant apparatus may include a bone tissue coupling part 10, a crown connection part 20, an abutment 30, and a crown 40.
  • the bone tissue coupling part 10 and the crown connection part 20 will be referred to as an implant post 1.
  • the crown connection part 20 may have a lower end connected to the bone tissue coupling part 10 and an abutment 30 coupled to the upper end.
  • the crown connection portion 20 is preferably formed integrally with the bone tissue coupling portion (10).
  • the implant has a detachable and detachable type in which the crown connection 20 is integrally formed with the abutment 30.
  • the separate type may be divided into an internal type and an external type according to the coupling structure of the crown connection part 20 and the abutment 30.
  • FIG. 1 illustrates an external type, embodiments according to the present invention can be applied to both an internal type and an external type.
  • the outer circumferential surface of the crown connection portion 20 may be formed to protrude so that the abutment 30 is inserted, and may be formed in various shapes.
  • the crown connection 20 may be in the form of a polygonal column.
  • a groove may be formed in the abutment 30 so that the crown connection part 20 may be inserted, and the shape of the groove may also be formed to correspond to the outer surface shape of the crown connection part 20.
  • the groove in the abutment 30 may be a groove having a polygonal pillar shape when the crown connection part 20 is a polygonal pillar.
  • the crown connection portion 20 is inserted into the abutment 30 as described above, and the outer surface of the crown connection portion 20 and the inner surface of the abutment 30 correspond to each other to the abutment on the crown connection portion 20. After combining the 30 can be prevented that the crown 40 is rotated or shifted position.
  • the upper surface of the crown connecting portion 20 may be formed with a female screw portion 22 (hereinafter, referred to as a 'female thread portion') for the crown coupling recessed toward the bone tissue coupling portion 10.
  • the abutment 30 may include an insertion hole 30b into which the crown coupling bolt 50 is inserted.
  • the crown fixing bolt 50 may firmly fix the crown 40 by engaging and fixing at least one of the abutment 30 and the crown connecting portion 20.
  • the crown 40 forms the appearance of an artificial tooth.
  • Crown 40 may be referred to as a crown, an artificial tooth, or the like.
  • the crown 40 may be installed in the crown connection portion 20 by being formed in the abutment 30 in the future.
  • the implant post 1 may be referred to as being divided into a body and a head.
  • the body of the implant post 1 refers to the part that is inserted into the pubis, and the head of the implant post 1 refers to the upper part of the body and refers to the part where the crown is joined. In most cases, the head of the implant post 1 can be understood as the same portion as the crown connection 20.
  • a screw retaining method for fixing the crown (crown) to the implant post 1 (or fixture) or abutment 30 by screws Although not shown in the present specification, the abutment 30 is screwed to the fixture, and a separately manufactured crown is disposed on the fixed abutment 30, with the crown and abutment interposed therebetween with dental cement. Embodiments according to the present invention may also be applied to the cement-retaining method of attaching the cement 30.
  • FIG 3 is a cross-sectional view showing that the implantable shielding membrane 121 covers the bone graft material 60 (also referred to as "bone graft material").
  • the implant post (1) is inserted into the alveolar bone (B) after dissecting the gum of the patient.
  • GBR Grafted bone regeneration
  • to increase the alveolar bone (B) by implanting angular artificial bone into the insufficient alveolar bone (B) or inserting a powdered artificial bone (bone graft 60) ) Can be performed.
  • the bone graft material 60 is filled, to ensure that the bone graft material (60) to maintain the required shape, to prevent the soft tissue intervention and to induce the bone tissue implantation membrane 121 may be used.
  • Implant shield film 121 as described above may be formed in a variety of shapes of a variety of materials.
  • the above-described implant shield membrane 121 covers the implant post 1 and the bone graft material 60 on the alveolar bone B, and the absorbent shield membrane 121A and the absorbent shield membrane 121A absorbed into the bone tissue after bone induction regeneration. It may include at least one of the non-absorbent shielding film 121B coupled to be exposed to the outer surface to maintain the shape of the absorbent shielding film 121A.
  • the absorbent shielding film 121A is made of a biodegradable material and performs a function of a barrier for a certain period of time, and then is decomposed and absorbed into tissue. It is divided into cross-linked type and non-cross-linked type, and it is absorbed from minimum 2 weeks to maximum 54 weeks and does not require additional removal technique. Even if the absorbent shield 121A is exposed to the outside or damaged, it acts as a barrier and has a low risk of infection.
  • Absorbent shield (121A) which is mainly made of collagen, polylactic acid, and polyglactic acid, does not require secondary surgery, prevents the migration of epithelial cells, forms a space, and is selective. Induces cell proliferation and bone regeneration.
  • the absorbent shielding film 121A is elastic and is used for the purpose of blocking mechanical stress applied to the wound.
  • the absorbent shielding film 121A may be representative of collagen, and is usually made by treating collagen obtained from an animal tendon or the like.
  • Such an absorbent shielding membrane 121A is known to be somewhat delayed in bone regeneration than the non-absorbing shielding membrane, and has less side effects than the non-absorbing shielding membrane 121B and is excellent in safety.
  • the space securing ability is somewhat lower than that of the non-absorbing shielding film 121B, and the effect as a support is small.
  • the non-absorbent shielding film 121B using a metal material such as titanium (Ti) is advantageous in that it is easy to secure a period required for cell proliferation by maintaining its shape and serving as a support.
  • the implant shield layer 121 may be formed of a bone component in addition to being formed as described above.
  • FIG. 4 is a perspective view showing an implant shield membrane 200 according to an embodiment of the present invention.
  • FIG. 5 is a perspective view illustrating a distal bone in which the shielding membrane 200 for the implant shown in FIG. 4 is formed.
  • the implantation shields 200 and 200A may include body parts 210 and 210A, which are bone components.
  • the bone component may be any one or combination of allogeneic bone, synthetic bone, and heterologous bone.
  • allogeneic bone refers to human bone.
  • the body parts 210 and 210A made of allogeneic bone may be made by shaving a portion of a bone of the patient or another person.
  • a portion of the alveolar bone on which the implant post (not shown) is to be mounted may be processed into a shell to form body parts 210 and 210A.
  • Allogeneic bone can be used to remove the antigenicity in the form of freezing the graft or freeze-drying, de-freeze-dried, and irradiated, and it takes a long period of bone formation and a small amount of newly produced bone, It can be used at any time and does not create additional surgical sites.
  • the allogeneic bones include demineralized freeze dried bone allografts (DFDBA), freeze dried bone allografts (FDBA), and irradiated cancellous bone (ICB).
  • DBA demineralized freeze dried bone allografts
  • FDBA freeze dried bone allografts
  • ICB irradiated cancellous bone
  • Heterogol means bones of animals such as cattle or pigs. It is an implant that expects bone conduction ability by dropping immune plaque through various processes, and it does not need to make additional surgical site and it can be used as much as you want, but it takes a long time to absorb and replace. What is understood as the mechanism of bone conduction rather than induction is the current flow. Examples of such heterogenous bones include Bio-Oss, ABM / P-15 and BioCera TM.
  • synthetic bone means artificially formed bone.
  • Synthetic bone may be formed by mixing different materials using a heterologous bone, which is an animal bone, as part of a component, or may be formed of a material that can substitute for a bone component.
  • These synthetic bones are not actual bones, but are artificially synthesized bones, so compared to other bone grafts, the quality is inferior and the time required for bone formation is long but inexpensive.
  • non-porous hydroxyapatite (HA), hydroxyapatite cement, porous hydroxyapatite, beta tricalcium phosphate, polymethlymethacrylate (PMMA) and hydroxyet-hylmethacrylate (HEMA) polymer, and bioactive glass are used in the clinical bone.
  • HA and PMMA and HEMA polymers are nonabsorbent, tricalcium phosphate and bioactive are absorbent.
  • Types of such synthetic bones include tricalcium phosphate, hard tissue individual polymers, and bioactive vitreous cera membranes.
  • the thickness of the body portion 210, 210A as described above is preferably in the form of a thin film so as to cover in close contact with the bone graft material (not shown) added to the loss of the alveolar bone (not shown).
  • the body parts 210 and 210A as described above may be formed in various forms.
  • the body parts 210 and 210A may be streamlined or curved.
  • the body parts 210 and 210A may be formed in a hemispherical shape, a spherical shape, an elliptic shape, or the like.
  • the body parts 210 and 210A may be formed in a plate shape in addition to the above cases.
  • the body parts 210 and 210A may be formed in various shapes in consideration of the shape of the alveolar bone and the arrangement of adjacent teeth.
  • the body parts 210 and 210A will be described in detail with reference to a case in which a part is formed to be bent.
  • the body part 210 of FIG. 4A may include a cover part 211 and a first bent part 212 formed by being bent from the cover part 211.
  • the body part 211 may be bent from the body part 211 and may include a second bent part 213 disposed to face the first bent part 212.
  • the cover portion 211 may cover the upper portion of the bone graft material implanted with the implant post, the first bent portion 211 may cover the side portion of the bone graft material.
  • the second bent portion 213 may extend to the normal alveolar bone.
  • the first and second bent portions 212 and 213 may be disposed in the vertical direction of the orthodontic direction. Specifically, any one of the first and second bent portions (212, 213) may be disposed in the lip direction around the alveolar bone, and the other one of the first and second bent portions (212, 213) to the alveolar bone It can be placed in the tongue direction as the center. At this time, the alveolar bone and the bone graft material may be disposed in the space between the first and second bent portions (212, 213), the first and second bent portions (212, 213) of the alveolar bone and the bone graft material The position shift can be prevented.
  • the body portion 210A of FIG. 4B may include a cover portion 211A and a first bent portion 212A.
  • the cover portion 211A and the first bent portion 212A may be the same as or similar to the cover portion 211A and the first bent portion 212A of FIG. Let's do it.
  • At least one of the cover portion 211A and the first bent portion 212A as described above may include a fixing member coupling portion 219A.
  • the fixing member (not shown) in the form of a screw or a wedge alveolar bone of the implant shield 200A, in particular any bent portion (eg, the first bent portion 212A), of the implant through the fixing member coupling portion 219A.
  • the fixing member coupling portion 219A may have a hole shape formed to penetrate the body portion 210A.
  • the shielding membranes 200 and 200A for the implant may be processed into sponge tissue 74 or dense bone 76, and may be processed to include both dense bone 76 and sponge tissue 74.
  • the implantation shields 200 and 200A will be described in detail with reference to the processing of the dense bone 76.
  • the implant shielding membranes 200 and 200A may be processed and extracted in the required shape from the dense bone 76 located at the outer side of the distal bone 70.
  • the heterogenous bone 70 is composed of a blood vessel portion 72, sponge tissue 74 and dense bone 76 from the center to the outer shell. Since the dense bone 76 area is higher than the other areas of bone density, the shielding membranes 200 and 200A for the implant may be processed and extracted in the required shape in the dense bone 76 area.
  • the implant shields 200 and 200A may be processed and extracted in a form that can be used in the distal bone 70 through a CAD / CAM or 3D printer.
  • the CAD / CAM may be designed to be cut and extracted in the form of a shielding film (200, 200A) formed to be bent at least a portion of the dense bone (76) located on the outer portion of the distal bone (70). have.
  • the surface of the implant shield (200, 200A) may be subjected to immune response removal treatment or infection blocking treatment.
  • This treatment can be a variety of post-treatment to be harmless to humans, such as low or high temperature treatment, lyophilization, treatment with chemicals, sterilization.
  • the implant shield membrane (200, 200A) can be processed by compression molding the different bone 70 or synthetic bone components in addition to the above case.
  • the shielding film may be processed in various forms.
  • the implant shields 200 and 200A may include protrusions 220 and 220A formed on the body portions 210 and 210A.
  • the protrusions 220 and 220A may be formed in the cover parts 211 and 211A to face the implant post.
  • the protrusions 220 and 220A will be described in detail later.
  • Figure 16 is a plan view showing the shape of the through-hole of the implant shield according to an embodiment of the present invention.
  • the implant shielding film 100 ′ includes a through hole 220 ′ instead of the protrusion 220 of the implant shielding film 100 illustrated in FIG. 4A.
  • the through hole 220 ′ may allow the cover screw (or healing abutment) to pass through the implant post so that the implant shields 200 and 200A may be fixed to the implant post.
  • the through hole may be circular as shown in FIG. 15.
  • the through hole is not limited thereto and may have various shapes.
  • the circular hole 220'-1 and the bar-shaped slit 220'-2 may be combined.
  • the bar-shaped slit 220'-2 may provide flexibility to allow the implant shield to pass through a portion of the post that is larger than the diameter of the circular hole 220'-1. Protrusions provided in the implant shielding film according to various embodiments to be described later may be replaced with through holes.
  • FIG. 6 is a cross-sectional view showing a portion to which an implant shielding membrane and an implant post procedure are shown in FIG.
  • the implant post 1 may be planted in the alveolar bone B after dissecting the gum (not shown) during the implant procedure.
  • the implant post 1 may include an internal implant post or an external implant post.
  • the implant post 1 will be described in detail with reference to a case in which the implant post 1 includes an internal implant post.
  • the alveolar bone (B) When planting the implant post 1 in the alveolar bone (B) as described above, the alveolar bone (B) may be in a state in which a portion is recessed or missing depending on the condition of the patient.
  • the implant post 1 When the implant post 1 is inserted into the missing portion as described above, the holding force of the post is lowered, a problem occurs in the aesthetic prosthesis, and may adversely affect the life of the post.
  • the bone graft material 60 may be filled in a portion where the alveolar bone B is recessed or lost. At this time, the bone graft 60 may be replaced with bone only after a certain time passes. Maintaining the shape of the bone graft material 60 by installing the implant shield 200 on the outer surface of the alveolar bone B and the bone graft material 60 until the bone graft material 60 is replaced with the alveolar bone B as described above. You can.
  • the bone tissue coupling part 10 may be inserted into the alveolar bone B.
  • at least a portion of the crown connection portion 20 may protrude to the outside of the alveolar bone (B).
  • the implant post (1) as described above may be inserted into the bone graft material (60) in the alveolar bone (B) after the alveolar bone (B) is missing.
  • the implant graft 60 may be installed in the portion where the bone graft material 60 is inserted or shielded membrane 200 for the implant described above to prevent the shape change.
  • the implant shield 200 may be disposed to cover the upper surface of the implant post 1 and a part of the bone graft material 60.
  • the cover part 211 may be disposed on the upper surface of the implant post 1
  • the first bent part 212 may be disposed to contact the bone graft material 60.
  • the second bent portion 213 may contact a portion of the alveolar bone B in a direction opposite to the first bent portion 212.
  • the positions of the first bent portion 212 and the second bent portion 213 are not limited to the above, but may be disposed opposite to each other.
  • the protrusion 220 may be inserted into the female screw portion of the crown connection portion 220.
  • the protrusion 220 may be inserted into the recess 153 of the temporary bolt 150.
  • the temporary bolt 150 is installed in the crown connection portion 20 for convenience of description, and the protrusion 220 will be described in detail with reference to the case where it is inserted into the recess 153.
  • the protrusion 220 as described above may be forcibly fitted into the recess 153.
  • the recess 153 may have a polygonal pillar, a cylinder, a cone, or a hemispherical shape in which a cross section of the recess 153 perpendicular to the longitudinal direction of the recess 153 is a regular polygon such as a regular hexagon.
  • the protrusion 220 may be formed in a cylinder, cone, hemisphere or polygonal polygonal shape of a regular polygon such as a regular hexagon. In this case, the shapes of the protrusion 220 and the recess 153 may be different from each other.
  • the concave portion 153 when the concave portion 153 is formed in a polygonal column shape, the cross section of the protrusion 220 may be formed in a cylinder, a cone, and a hemispherical shape.
  • the concave portion 153 when the concave portion 153 is formed in a cylinder, cone, hemispherical shape, the protrusion 220 may be formed in a regular polygonal column shape.
  • the concave portion 153 is formed in a regular pillar shape for convenience of description, and the protrusion 220 will be described in detail with reference to a case in which it is formed in a cylindrical shape.
  • the diameter of either cross section of the protrusions 220 is greater than the shortest separation distance of the inner ends opposed to each other with respect to the center of the cross section of the recesses 153 so that the protrusions 220 are appropriately fitted to the recesses 153.
  • the center of the recess 153 may be smaller than the longest separation distance between the inner ends that face each other.
  • the implant shield membrane 200 may be mounted vertically to the implant post 1 after determining the position and direction of the implant shield membrane 200 during the procedure, and if there is an error in the orientation, the implant shield membrane ( The operation of rotating 200 can easily correct the error.
  • the protrusion 220 as described above may be formed of the same material as or similar to the body portion 210.
  • the protrusion 220 may be formed of at least one of allogeneic bone, xenograft, and synthetic bone.
  • the protrusion 220 may be integrally formed when the body portion 210 is formed, or may be separately manufactured to be coupled to the body portion 210.
  • the protrusion 220 may be formed of a material different from that of the body 210.
  • the protrusion 220 may be formed of a metal material such as titanium or a plastic material such as resin or engineering plastic.
  • the protrusion may be formed by mixing a metal and a plastic material.
  • the protrusion 220 may be manufactured separately from the body 210 and installed on the body 210.
  • the protrusion 220 may be formed of a metal material or a plastic material, and then a part of the protrusion 220 may be inserted into and coupled to the body 210 or may be fixed to the body 210 through an adhesive material.
  • the protrusion 220 will be described in detail with reference to a case in which the protrusion 220 is integrally formed with the body 210.
  • the bone graft material 60 may be completely bonded to the alveolar bone B.
  • the implant shield 200 may help to securely secure the bone graft (60) to the alveolar bone (B) by maintaining the shape of the bone graft (60).
  • the implant shield membrane 200 may be formed of a bone component to help the bone graft material 60 to rest in the alveolar bone B in a short time.
  • FIG. 7 is a cross-sectional view showing a portion to which the implant shielding membrane 200A and the implant post 1 procedure shown in FIG. 4B are applied.
  • the shape of the bone graft material 60 may be maintained using the implant shield 200A during the implant procedure.
  • the implant shield 200A may support the bone graft material 60 by being installed to cover a portion of the implant post 1, the bone graft material B, and the alveolar bone 60 as described above with reference to FIG. 6.
  • the protrusion 220A may be installed to be inserted into the recess 153 of the temporary bolt 150
  • the cover portion 211A may be installed to cover the upper surface of the implant post (1).
  • the first bent portion 212A may be installed to cover the portion of the bone graft material (60).
  • the fixing member 300 may be coupled to the fixing member coupling part 219A. Specifically, after the body portion 210A is disposed as described above, when the fixing member 300 is coupled to the fixing member coupling portion 219A, the fixing member 300 penetrates through the body portion 210A to allow the bone graft material 60 to form. It can be inserted into the part. That is, the fixing member 300 may prevent the bone graft material 60 from moving to the first bent portion 212A by completely contacting the first bent portion 212A to the bone graft material 60. At this time, the fixing member 300 may be formed in the form of bolts, screws, pins and the like.
  • the implant shield 200A may help the bone graft 60 to settle in a short time.
  • the implant shield membrane 200A may maintain the shape of the bone graft material 60 by fixing the body portion 210A to at least one of the alveolar bone B and the bone graft material 60 through the fixing member 300.
  • FIG. 8 is a perspective view showing an implant shield (200C) according to another embodiment of the present invention.
  • the shielding film 200C for the implant may include a body portion 210C formed in a hemispherical shape. At this time, a space may be formed inside the body portion 210C. At least one of an implant post (not shown) and a bone graft material (not shown) may be disposed and covered in an internal space of the body portion 210C as described above.
  • the body portion 210C may be formed of a bone component. In this case, since the bone component may be formed in the same or similar to that described above, a detailed description thereof will be omitted.
  • the implant shield layer 200C may include a protrusion 220C formed in an internal space of the body portion 210C.
  • the protrusion 220C may prevent the position of the implant shielding film 200C from being deviated during the implant procedure.
  • the protrusion 220C may be selectively formed or not formed in the body portion 210C, and hereinafter, the protrusion 220C is formed at the central portion inside the body portion 210C for convenience of description. This will be described in detail.
  • the implant shield membrane 200C as described above may be installed to cover at least one of the implant post and the bone graft material after the bone graft material.
  • at least one of the implant post and the bone graft material may be inserted into the body portion 210C to reduce the shape change of the bone graft material until hardening of the bone graft material is completed.
  • the protrusion 220C may be coupled to the implant post to fix the body portion 210C.
  • the method and structure in which the protrusion 220C is coupled to the implant post has been described in detail above, and thus a detailed description thereof will be omitted.
  • the implant shielding membrane 200C may be processed in various forms to assist in curing the bone graft material.
  • the implant shield (220C) is formed of a bone component can minimize the side effects caused during the procedure as well as shorten the curing time of the bone graft material.
  • FIG. 9 is a perspective view illustrating a shield 200D for an implant according to another embodiment of the present invention.
  • the shielding film 200D for the implant may include a space formed therein, and may include a body portion 210D having an opening 218D to open the space.
  • the body portion 210D may be formed of a bone component, and may be formed in various forms.
  • the body portion 210D may be formed in a polygonal column shape, and may be formed in a semi-cylindrical shape, a cone shape, a wedge shape, or the like.
  • the body portion 210D will be described in detail with reference to a case where the body portion 210D is formed in a square pillar shape for convenience of description.
  • the body portion 210D as described above may include a cover portion 211D and a bent portion 212D.
  • the bent portion 212D may be bent and connected to the cover portion 211D.
  • the bent portion 212D may be connected to the cover portion 211D to completely cover the outer surface of the cover portion 211D.
  • the body portion 210D may be formed as described above, and may include an opening 218D on a surface of the body portion 210D that faces the cover portion 211D.
  • the body portion 210D may have a space formed between the cover portion 211D and the bent portion 212D so that at least one of an implant post (not shown) and a bone graft material (not shown) may be inserted therein.
  • the implant shield 200D may include a protrusion 220D protruding from the body portion 210D.
  • the protrusion 220D may be formed on the cover 211D. In this case, since the protrusion 220D is the same as or similar to that described above, a detailed description thereof will be omitted.
  • the implant shield membrane 200D formed as described above may be installed on the alveolar bone during the procedure.
  • at least one implant post may be inserted into a space inside the body 210D.
  • a portion of the bent portion 212D supports the alveolar bone and the bone graft material, and another portion of the bent portion 212D is inserted into at least one of the plaque and bone graft material.
  • the protrusion 220D may be installed to be inserted into the recess (not shown) of the temporary bolt (not shown) to support the body portion 210D as described above.
  • Implant shielding film 200D does not need to be removed separately during implantation, so no additional secondary surgery is required.
  • FIG. 10 is a perspective view showing an implant shield (200E) according to another embodiment of the present invention.
  • the implant shield film 200E may include a body portion 210E having a space formed therein.
  • the body portion 210E may be formed of a bone component, and may include a cover portion 211E and a bent portion 212E formed by bending from the cover portion 211E.
  • the bent portion 212E may be disposed to surround the outer surface of the cover portion 211E, and the cover portion 211E and the bent portion 212E may form a space therein.
  • Cover portion 211E and the bent portion 212E formed as described above may be formed in a curved surface having a radius of curvature to correspond to the teeth.
  • the radius of curvature of the cover portion 211E and the radius of curvature of the bent portion 212E may be formed to be constant, it may be formed to be provided in plurality.
  • the radius of curvature of the cover portion 211E and the radius of curvature of the bent portion 212E will be described in detail with reference to a case where the shape is constant.
  • the cover portion 211E and the bent portion 212E will be described in detail with a focus on the case each formed in a fan shape.
  • the body portion 210E may include a coupling portion 290E coupled to an abutment (not shown) coupled to an implant post (not shown).
  • the coupling part 290E may be formed in a hole or groove shape, and in particular, the coupling part 290E may be formed to penetrate the cover part 211E.
  • the coupling part 290E will be described in detail with reference to a case of a hole shape passing through the cover part 211E.
  • the implant shield film 200E formed as described above may be suitable when simultaneously performing a plurality of implants.
  • the implant shield (200E) can be used during the implantation procedure of the tooth extracted entirely.
  • at least one implant post may be disposed in the body portion 210E.
  • the implanted shield film 200E formed as described above may be manufactured in consideration of the oral structure of the patient, that is, the shape and arrangement of the alveolar bone (not shown).
  • a bone graft material (not shown) is disposed on the alveolar bone, and the body portion 210E of the shield 200E for the implant may be disposed to surround at least one of the alveolar bone and the bone graft material.
  • the coupling portion 290E formed on the cover portion 211E may be formed in consideration of the position of the implant post to be planted in advance, and may be formed to correspond to the crown coupling portion (not shown).
  • a temporary bolt (not shown) is inserted into the coupling portion to form a female screw portion (not shown) and an insertion groove formed in the crown coupling portion. (Not shown) can be shielded.
  • the implant post 200E may reduce the shape change of the bone graft by supporting the bone graft through the body portion 210E.
  • the implant post 200E can predict the shape of the bone graft in advance, the operator can easily predict the amount of bone formation.
  • 11 is a perspective view showing an implant shield (200F) according to another embodiment of the present invention.
  • 12 is a cross-sectional view taken along line A-A and line B-B of FIG.
  • the implant shield film 200F may include a body portion 210F formed of a bone component and a protrusion 220F formed on the body portion 210F.
  • the body portion 210F may include a cover portion 211F and a bent portion 212F formed by being bent from the cover portion 211F.
  • the cover portion 211F and the bent portion 212F as described above may be connected to each other to form a space therein.
  • at least one of the alveolar bone (not shown) and bone graft material (not shown) may be inserted into the internal space.
  • the cover portion 211F and the bend portion 212F may each be formed as a curved surface having a radius of curvature. At this time, the cover portion 211F and the bent portion 212 may be formed in a curved surface in the longitudinal direction, respectively. In addition, the cover portion 211F may be formed as a curved surface in the height direction of the bent portion 212.
  • the radius of curvature of the cover portion 211F and the radius of curvature of the bent portion 212F in the longitudinal direction as described above may be constant, and may be different from each other.
  • the cover portion 211F and the bent portion 212F may be formed in a curved surface corresponding to the teeth.
  • the cross section of the body portion 210F as described above may be variously formed.
  • the cross section of the body portion 210F may be an arch of a 'U' shape, such as 'c' or horseshoe.
  • the cross-sectional shape of the body portion 210F is not limited to the above, and may be variously formed according to the shape of the teeth or the alveolar bone, the arrangement form of the bone graft material, the overall shape due to the bone graft material, and the like. (a) and (b))
  • the cover portion 211F may be provided with a coupling portion 290F into which the fastening mechanism is inserted from the outside.
  • the coupling part 290F may be formed in the cover part 211F.
  • Coupling portion 290F may be formed the same as or similar to that described above.
  • the coupling part 290F may be formed to penetrate the cover part 211F, and may be formed to penetrate the cover part 211F and the protrusion part 212F.
  • the coupling portion 290F may be fixed by inserting an abutment (not shown), a crown coupling bolt (not shown), or the like coupled to a temporary bolt (not shown) or an implant post (not shown).
  • the coupling part 290F will be described in detail with reference to the case where the cover part 211F is formed to penetrate only.
  • the coupling portion 290F and the protrusion 220F may be disposed to alternate with each other.
  • the implant shield membrane (200F) formed as described above can maintain the shape of the bone graft material when the bone graft material is installed.
  • the shield 200F for the implant may be fixed by coupling the protrusion 220F to the implant post.
  • the abutment bolt When the hardening of the bone graft is completed, the abutment bolt may be inserted into the coupling part 290F to fix the abutment.
  • the fixing method of the abutment is not limited to the above, it is also possible to fix the crown coupling bolt through the coupling portion 290F to the female screw portion of the crown connection portion.
  • the implant shielding membrane 200F is formed of a bone component, the damage portion of the tooth is very small, and thus the bone formation site is relatively small. Bar is manufactured and used directly in the procedure, there is an advantage that the absorption and shielding properties and retention properties for the bone generating part is improved.
  • FIG. 13 is a perspective view of an implant shield (200G) according to another embodiment of the present invention.
  • the shielding film 200G for the implant may include a body portion 210G and a protrusion 220G.
  • the body portion 210G may include a cover portion 211G and a bent portion (not shown).
  • the body portion 210G may be formed the same as or similar to that shown in FIGS. 4 to 10.
  • the body portion 210G is not limited to the above, and may include any shape capable of maintaining the shape of a bone graft material (not shown). However, in the following description, the body portion 210G will be described in detail with reference to a case in which the body portion 210G is formed the same as or similar to that shown in FIG.
  • the body portion 210G as described above may include a cover portion 211G, a first bent portion 212G, and a second bent portion 213G.
  • the first bent part 212G and the second bent part 213G may be formed to extend from the cover part 211G and be bent from the cover part 211G.
  • the implant shielding film 200G may include a pad part 240G installed in the body part 210G.
  • the pad part 240G may be installed on at least one of the cover part 211G, the first bent part 212G, and the second bent part 213G.
  • the pad portion 240G may be installed in the body portion 210G so that a portion of the alveolar bone (not shown) is disposed.
  • the pad part 240G may be formed in various shapes. Specifically, the pad portion 240G may be formed to correspond to the shape of the portion where the alveolar bone is removed. For example, the pad portion 240G may have a rectangular pillar shape, and may be variously formed, such as a cone or an elliptical pad.
  • the pad portion 240G as described above may be manufactured by freeze-drying the bone graft material on the body portion 210G.
  • the pad portion 240G may be applied to one surface of the body portion 210G in a predetermined thickness and area.
  • the thickness and area of the pad portion 240G may be determined according to the degree of deficiency of the alveolar bone, deformation of the alveolar bone due to extraction.
  • the implant shield (200G) can increase the ease of use by installing the bone graft material to the body portion 210G in a pad form.
  • the implant shield 200G may be formed of a bone component to reinforce the alveolar bone after the procedure, and to prevent the shape of the bone graft from varying when the bone graft is cured.
  • FIG. 14 is a perspective view of an implant shield (200H) according to another embodiment of the present invention.
  • the implantation shield 200H may include a body 210H and a protrusion 220H.
  • the body portion 210H may include a cover portion 211H and a bent portion (not shown).
  • the body portion 210H may be formed the same as or similar to that shown in FIGS. 4 to 10.
  • the body portion 210H is not limited to the above, and may include any shape capable of maintaining the shape of the bone graft material (not shown). However, hereinafter, the body portion 210H will be described in detail with reference to a case in which the body portion 210H is formed the same as or similar to that shown in FIG.
  • the body portion 210H as described above may include a cover portion 211H, a first bent portion 212H, and a second bent portion 213H.
  • the first bent part 212H and the second bent part 213H may be formed to extend from the cover part 211H and be bent from the cover part 211H.
  • the body portion 210H as described above may be formed through the hole 280H to penetrate the body portion 210H.
  • the through hole 280H may be formed only in a partial region of the body portion 210H.
  • the through hole 280H may be formed only in the cover portion 211H, and may be formed only in the first bent portion 212H or the second bent portion 213H.
  • the through hole 280H may be formed only in the cover portion 211H and the first bent portion 212H, or may be formed only in a partial region of the second bent portion 213H.
  • the through hole 280H will be described in detail with reference to a case where only the first bent portion 212H is formed.
  • a plurality of through holes 280H as described above may be provided.
  • the diameters of the plurality of through holes 280H may be the same or different from each other.
  • the diameter of the through hole 280H formed at the center of the first bent portion 211H among the plurality of through holes 280H may be larger than the diameter of the through hole 280H of the other portion.
  • the diameter of the through hole 280H may be formed to gradually decrease toward the outside of the first bent portion 212H around the center portion of the first bent portion 280H.
  • the diameter of the through hole 280H may be smaller than the center portion of the bent portion 280H.
  • the most dense portion of the diameter bone graft material (not shown) of the through hole 280H may be formed larger than other portions.
  • the diameter of the plurality of through holes 280H will be described in detail with reference to the same case for convenience of description.
  • the body portion 210H as described above is partially passed through the blood or bone growth factors, but the amount may be very small.
  • the plurality of through holes 280H may serve as a passage for supplying blood or bone growth factors from the gingiva (not shown) to the bone graft material (not shown) inside the implantation shield 200H.
  • the bone graft material may be smoothly regenerated in the alveolar bone (not shown) due to blood or bone growth factors, which are moved through the plurality of through holes 280H.
  • the implant shield (200H) is formed of a bone component can not only reinforce the alveolar bone after the procedure, but also prevent the shape of the bone graft material from varying when the bone graft material is cured.

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dental Prosthetics (AREA)

Abstract

Disclosed is a barrier membrane for an implant. The present invention relates to a barrier membrane for an implant comprising a body portion for covering an implant post bonded to the alveolar bone and the bone graft material added around the alveolar bone for guided bone regeneration, wherein the body portion may be made of bone components.

Description

임플란트용 차폐막Implant Shield
본 발명은 차폐막에 관한 것으로, 더 상세하게는 임플란트용 차폐막에 관한 것이다.The present invention relates to a shielding film, and more particularly to a shielding film for implants.
치아 임플란트 시술은 대체적으로, 환자의 잇몸을 절개한 후 그 속에 있는 잇몸뼈(이를 '치조골'이라 한다)에 임플란트용 포스트를 삽입하고, 임플란트용 포스트에 인공치아(Crown)를 결합함으로써 완성된다.The dental implant procedure is generally completed by dissecting the patient's gums and inserting an implant post into the gum bone (called 'alveolar bone') therein, and joining an artificial tooth (Crown) to the implant post.
임플란트 시술을 하기 위해서는 픽스쳐가 식립되는 치조골은 충분한 길이와 폭이 필요하다. 뼈는 다른 조직에 흡수되거나 소실되는 경우가 많다. 이 경우 뼈유도 재생술(이를 '골유도 재생술'이라고도 한다)이 필요한데, 뼈는 다른 조직과 달리 신체의 구조로 완전히 회복되는 유일한 잠재력을 가지고 있다. 그러나, 뼈가 올바른 형태로 재생되기 위해서는 기본적인 상태가 필요한데, 기계적 안정성과 풍부한 혈액 공급이 그것이다.In order to perform an implant, the alveolar bone in which the fixture is placed needs sufficient length and width. Bones are often absorbed or lost by other tissues. In this case, bone guidance regeneration (also called 'bone regeneration') is required. Unlike other tissues, bone has the only potential to fully recover the body's structure. However, a basic condition is required for bones to regenerate in the correct form: mechanical stability and abundant blood supply.
골유도 재생술의 생물학적 필요조건은 혈류의 공급, 안정화, 골아세포, 제한된 공간, 공간 유지, 창상피개 등이 있으며, 이를 위해 여러 외과적 술식이 시행된다. 골 이식재에 적절한 압력을 제공하는 경우, 밀착성이 높아지고 골 형성에 도움을 줄 수 있다.Biological requirements for bone induction regeneration include blood supply, stabilization, osteoblasts, limited space, space retention, and incisional wounds. Several surgical procedures are performed for this purpose. Providing proper pressure on the bone graft can increase adhesion and help bone formation.
특히, 안정화 및 제한된 공간을 위해 차폐막을 사용한다. 차폐막은 혈병을 보호해주고, 연조직 세포가 골 결손부로 이주해 오는 것을 막고 골성 세포가 자리를 잡을 수 있도록 해주는 역할을 한다.In particular, shielding membranes are used for stabilization and limited space. The shield helps protect blood clots, prevents soft tissue cells from migrating to bone defects, and allows bone cells to settle.
본 발명의 실시예들은 안정적으로 골 이식재를 지지하여 골재생 유도술을 시술 가능한 임플란트용 차폐막을 제공하고자 한다.Embodiments of the present invention to stably support the bone graft material to provide an implantable shield membrane that can be performed to guide bone regeneration.
본 발명의 일 측면은, 치조골에 결합된 임플란트 포스트 및 상기 치조골 주위에 골재생 유도술을 위하여 첨가되는 골 이식재를 덮는 바디부를 포함하는 임플란트용 차폐막에 있어서, 상기 바디부는 골 성분으로 형성되는 임플란트용 차폐막을 제공할 수 있다.In one aspect of the present invention, in the implant membrane comprising an implant post coupled to the alveolar bone and a body portion covering the bone graft material added for induction of bone regeneration around the alveolar bone, the body portion for implants formed of bone components A shielding film can be provided.
또한, 상기 바디부는 일측으로 구부러지도록 형성된 적어도 하나의 절곡부를 포함할 수 있다. 또한, 상기 골 성분으로 형성되는 상기 바디부는 이종골 또는 합성골일 수 있다. 또한, 상기 바디부는 상기 이종골을 절삭 가공하여 형성될 수 있다. 또한, 상기 바디부는 내부에 공간이 형성되며, 상기 공간의 개구부를 통하여 상기 임플란트 포스트 및 상기 골 이식재 중 적어도 하나가 삽입되도록 설치될 수 있다. 또한, 임플란트용 차폐막은 상기 바디부로부터 돌출되어 형성되는 돌출부를 더 포함할 수 있다. 또한, 상기 바디부와 상기 돌출부는 서로 상이한 재질로 형성될 수 있다. 또한, 상기 돌출부는 금속 재질 및 플라스틱 재질 중 적어도 어느 한 재질로 형성될 수 있다. 또한, 상기 돌출부는, 상기 임플란트 포스트의 상부면에 형성된 치관 결합용 암나사부 또는 상기 치관 결합용 암나사부에 체결되는 임시볼트의 상부면에 형성된 형성된 오목부에 억지끼움 결합될 수 있다. 또한, 임플란트용 차폐막은 상기 골 이식재로 형성되며, 상기 바디부에 패드 형태로 부착되는 패드부를 더 포함할 수 있다. 또한, 상기 바디부는 표면에는 관통하도록 통공이 형성될 수 있다. 또한, 상기 통공은 복수개 구비되며, 상기 복수개의 통공은 지름이 서로 상이할 수 있다. 또한, 상기 통공은 상기 바디부의 일부 영역에만 형성될 수 있다. 또한, 상기 바디부는, 상기 치조골 및 상기 골 이식재 중 적어도 하나와 상기 바디부를 고정시키는 고정부재가 결합하는 고정부재결합부를 구비할 수 있다. 또한, 상기 바디부의 적어도 일면은 치열에 대응되는 곡률반경을 갖는 곡면으로 형성될 수 있다.In addition, the body portion may include at least one bent portion formed to be bent to one side. In addition, the body portion formed of the bone component may be a heterologous bone or synthetic bone. In addition, the body portion may be formed by cutting the distal bone. In addition, a space is formed inside the body portion, and may be installed so that at least one of the implant post and the bone graft material is inserted through the opening of the space. In addition, the implant shield may further include a protrusion formed to protrude from the body portion. In addition, the body portion and the protrusion may be formed of different materials. In addition, the protrusion may be formed of at least one of a metal material and a plastic material. In addition, the protruding portion may be tightly coupled to a concave portion formed on the upper surface of the temporary bolt fastened to the female coupling portion or the crown coupling female screw portion formed on the upper surface of the implant post. In addition, the implant shield is formed of the bone graft material, and may further include a pad portion attached to the body portion in the form of a pad. In addition, the body portion may be formed through the through-holes. In addition, the plurality of through holes are provided, the plurality of through holes may be different from each other in diameter. In addition, the through hole may be formed only in a portion of the body portion. The body part may include a fixing member coupling part to which at least one of the alveolar bone and the bone graft material and a fixing member fixing the body part are coupled. In addition, at least one surface of the body portion may be formed as a curved surface having a radius of curvature corresponding to the teeth.
본 발명의 실시예들은 골 성분으로 이루어짐으로써 골재생 유도술을 시행한 후 골 이식재에 쉽게 흡수됨은 물론, 하방의 골 이식재를 안정적으로 지지함으로써 골 재생 공간을 효과적으로 확보할 수 있다.Embodiments of the present invention can be easily absorbed by the bone graft material after the bone regeneration guided by the bone component, as well as to secure the bone regeneration space by stably supporting the bone graft below.
도 1은 치과용 임플란트 기구가 식립된 것을 도시한 모식도, 도 2는 익스터널형 치과용 임플란트 기구 및 인터널형 치과용 임플란트 기구의 단면을 나타낸 단면도, 도 3은 임플란트용 차폐막이 골 이식재를 덮고 있는 것을 도시한 단면도, 도 4는 본 발명의 일 실시예에 따른 임플란트용 차폐막을 나타내는 사시도, 도 5은 도 4에 도시된 임플란트용 차폐막이 형성된 이종골을 보여주는 사시도, 도 6은 도 4의 (a)에 도시된 임플란트용 차폐막 및 임플란트 포스트 시술이 적용된 부분을 보여주는 단면도, 도 7은 도 4의 (b)에 도시된 임플란트용 차폐막 및 임플란트 포스트 시술이 적용된 부분을 보여주는 단면도, 도 8은 본 발명의 다른 실시예에 따른 임플란트용 차폐막을 보여주는 사시도, 도 9는 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막을 보여주는 사시도, 도 10은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막을 보여주는 사시도, 도 11은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막의 사시도, 도 12는 도 11의 A-A선 및 B-B선을 따라 취한 단면도, 도 13은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막의 사시도, 도 14는 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막의 사시도, 도 15는 본 발명의 또다른 실시예에 따른 임플란트 차폐막의 사시도, 및 도 16은 본 발명의 실시예에 따른 임플란트 차폐막의 관통홀의 형상을 나타내는 평면도이다.1 is a schematic diagram showing that the dental implant device is implanted, Figure 2 is a cross-sectional view showing the cross-sectional view of the external dental implant device and internal dental implant device, Figure 3 is a shield for the implant covering the bone graft material Figure 4 is a perspective view showing an implant shield according to an embodiment of the present invention, Figure 5 is a perspective view showing a distal bone formed with the implant shield is shown in Figure 4, Figure 6 is a (a ) Is a cross-sectional view showing a portion of the implant membrane and the implant post procedure is applied, Figure 7 is a cross-sectional view showing a portion for the implant membrane and implant post procedure shown in Figure 4 (b), Figure 8 is a view of the present invention 9 is a perspective view showing a shield for an implant according to another embodiment, FIG. 9 shows a shield for an implant according to another embodiment of the present invention. 10 is a perspective view showing an implant shield according to another embodiment of the present invention, FIG. 11 is a perspective view of an implant shield according to another embodiment of the present invention, FIG. 12 is a line AA and BB of FIG. 13 is a perspective view of an implant shield according to another embodiment of the present invention, FIG. 14 is a perspective view of an implant shield according to another embodiment of the present invention, and FIG. 15 is another embodiment of the present invention. A perspective view of an implant shield membrane according to an example, and FIG. 16 is a plan view illustrating a shape of a through hole of an implant shield membrane according to an embodiment of the present invention.
이하, 본 발명에 따른 임플란트용 차폐막의 바람직한 일실시예를 첨부된 도면을 참조하여 상세하게 설명하기로 한다. 첨부된 도면은 본 발명의 예시적인 형태를 도시한 것으로, 이는 본 발명을 보다 상세히 설명하기 위해 제공되는 것일 뿐, 이에 의해 본 발명의 기술적인 범위가 한정되는 것은 아니다.Hereinafter, with reference to the accompanying drawings a preferred embodiment of the implant shield membrane according to the present invention will be described in detail. The accompanying drawings show exemplary forms of the present invention, which are provided to explain the present invention in more detail, and the technical scope of the present invention is not limited thereto.
치과용 임플란트 기구는 일반적으로 부분적 또는 전체적으로 치아가 상실된 부위에 인공치근인 픽스쳐(fixture)를 심어 치조골에 유착시키고, 인공치근에 치아 보철을 고정하여 형성된 인공 치아 구조를 의미한다. 임플란트라는 용어는 넓게 이러한 치과 시술 방법을 포함하는 포괄적 개념으로 사용될 수 있고, 좁게는 픽스쳐와 동일한 의미로 사용될 수 있다. 본 명세서에서는 임플란트 또는 임플란트 구조는 주로 일반적인 인공 치아 구조로 사용될 수 있다.A dental implant device generally refers to an artificial dental structure formed by implanting a fixture, which is an artificial tooth root, at a part or a whole where a tooth is lost, thereby adhering it to the alveolar bone, and fixing the dental prosthesis to the artificial tooth root. The term implant can be used broadly to encompass such a concept as a dental procedure and can be used as narrowly as a fixture. In the present specification, the implant or implant structure may be mainly used as a general artificial tooth structure.
도 1은 치과용 임플란트 기구가 식립된 것을 도시한 모식도이다. 도 2는 임플란트 기구의 단면을 나타낸 단면도이다.1 is a schematic diagram showing that the dental implant mechanism is placed. 2 is a cross-sectional view showing a cross section of the implant mechanism.
도 1 및 도 2를 참조하면, 치과용 임플란트 기구는 골조직 결합부(10), 치관 연결부(20), 어버트먼트(30) 및 치관(40)을 포함할 수 있다. 골조직 결합부(10) 및 치관 연결부(20)를 임플란트 포스트(1)라 칭하기로 한다.1 and 2, the dental implant apparatus may include a bone tissue coupling part 10, a crown connection part 20, an abutment 30, and a crown 40. The bone tissue coupling part 10 and the crown connection part 20 will be referred to as an implant post 1.
치관 연결부(20)는 하단부가 골조직 결합부(10)와 연결되고 상단부에 어버트먼트(30)가 결합될 수 있다. 치관 연결부(20)는 골조직 결합부(10)와 일체로 형성되는 것이 바람직하다.The crown connection part 20 may have a lower end connected to the bone tissue coupling part 10 and an abutment 30 coupled to the upper end. The crown connection portion 20 is preferably formed integrally with the bone tissue coupling portion (10).
임플란트는 치관 연결부(20)가 어버트먼트(30)와 일체로 형성된 일체형과 분리 가능한 분리형이 있다. 분리형은 치관 연결부(20)와 어버트먼트(30)의 결합 구조에 따라 인터널(internal)형 및 익스터널(external)형으로 구분될 수 있다. 도 1은 익스터널 형에 대해 도시하나, 본 발명에 따른 실시예들은 인터널 및 익스터널 형 모두에 적용될 수 있다.The implant has a detachable and detachable type in which the crown connection 20 is integrally formed with the abutment 30. The separate type may be divided into an internal type and an external type according to the coupling structure of the crown connection part 20 and the abutment 30. Although FIG. 1 illustrates an external type, embodiments according to the present invention can be applied to both an internal type and an external type.
치관 연결부(20)의 외주면은 어버트먼트(30)가 삽입되도록 돌출되어 형성될 수 있으며, 형태가 다양하게 형성될 수 있다. 예를 들면, 치관 연결부(20)는 다각 기둥 형태일 수 있다. 어버트먼트(30)의 내부에는 치관 연결부(20)가 삽입되도록 홈이 형성될 수 있으며, 상기 홈의 형태도 치관 연결부(20)의 외면 형상에 대응되도록 형성될 수 있다. 구체적으로 어버트먼트(30) 내부의 홈은 치관 연결부(20)가 다각 기둥인 경우 다각 기둥 형태의 홈이 형성될 수 있다. 이때, 상기와 같이 치관 연결부(20)는 어버트먼트(30)에 삽입되고, 치관 연결부(20)의 외면과 어버트먼트(30)의 내면이 서로 대응됨으로써 치관 연결부(20)에 어버트먼트(30)를 결합한 후 치관(40)이 회전하거나 위치가 어긋나는 것을 방지할 수 있다. The outer circumferential surface of the crown connection portion 20 may be formed to protrude so that the abutment 30 is inserted, and may be formed in various shapes. For example, the crown connection 20 may be in the form of a polygonal column. A groove may be formed in the abutment 30 so that the crown connection part 20 may be inserted, and the shape of the groove may also be formed to correspond to the outer surface shape of the crown connection part 20. Specifically, the groove in the abutment 30 may be a groove having a polygonal pillar shape when the crown connection part 20 is a polygonal pillar. At this time, the crown connection portion 20 is inserted into the abutment 30 as described above, and the outer surface of the crown connection portion 20 and the inner surface of the abutment 30 correspond to each other to the abutment on the crown connection portion 20. After combining the 30 can be prevented that the crown 40 is rotated or shifted position.
치관 연결부(20)의 상면에는 골조직 결합부(10)를 향하여 함몰되게 치관 결합용 암나사부(22)(이하, '암나사부'라 칭한다)가 형성될 수 있다. 어버트먼트(30)는 치관 결합용 볼트(50)가 삽입되는 삽입홀(30b)을 구비할 수 있다. 치관 고정용 볼트(50)는 어버트먼트(30) 및 치관 연결부(20) 중 적어도 하나를 결합시켜 고정시킴으로써 치관(40)을 견고하게 고정시킬 수 있다.The upper surface of the crown connecting portion 20 may be formed with a female screw portion 22 (hereinafter, referred to as a 'female thread portion') for the crown coupling recessed toward the bone tissue coupling portion 10. The abutment 30 may include an insertion hole 30b into which the crown coupling bolt 50 is inserted. The crown fixing bolt 50 may firmly fix the crown 40 by engaging and fixing at least one of the abutment 30 and the crown connecting portion 20.
치관(40)은 인공치아의 외관을 형성한다. 치관(40)은 크라운(crown), 인공치아 등으로 지칭될 수 있다. 이때, 치관(40)은 어버트먼트(30)에 향후에 형성됨으로써 치관 연결부(20)에 설치될 수 있다.The crown 40 forms the appearance of an artificial tooth. Crown 40 may be referred to as a crown, an artificial tooth, or the like. At this time, the crown 40 may be installed in the crown connection portion 20 by being formed in the abutment 30 in the future.
임플란트 포스트(1)는 몸체와 헤드로 나눠서 지칭될 수 있다. 임플란트 포스트(1)의 몸체는 치골에 삽입되는 부분을 지칭하며, 임플란트 포스트(1)의 헤드는 몸체의 상부를 지칭하는 것으로 치관이 결합되는 부분을 지칭한다. 대부분 임플란트 포스트(1)의 헤드는 치관 연결부(20)와 동일한 부분으로 이해될 수 있다.The implant post 1 may be referred to as being divided into a body and a head. The body of the implant post 1 refers to the part that is inserted into the pubis, and the head of the implant post 1 refers to the upper part of the body and refers to the part where the crown is joined. In most cases, the head of the implant post 1 can be understood as the same portion as the crown connection 20.
지금까지, 도 1 및 도 2는 치관(크라운(crown))을 임플란트 포스트(1)(또는 픽스쳐)나 어버트먼트(30)에 나사에 의해 고정하는 나사유지형 방식을 도시하였지만 이에 한정되지 않는다. 본 명세서에서 도시하지 않았지만, 픽스쳐에 어버트먼트(30)를 나사 고정하고, 별도로 제작된 크라운을 고정된 어버트먼트(30) 위에 배치하여, 그 사이에 치과용 시멘트를 개재하여 크라운과 어버트먼트(30)를 합착하는 시멘트 유지형 방식도 본 발명에 따른 실시예들이 적용될 수 있다.1 and 2 have shown, but not limited to, a screw retaining method for fixing the crown (crown) to the implant post 1 (or fixture) or abutment 30 by screws. Although not shown in the present specification, the abutment 30 is screwed to the fixture, and a separately manufactured crown is disposed on the fixed abutment 30, with the crown and abutment interposed therebetween with dental cement. Embodiments according to the present invention may also be applied to the cement-retaining method of attaching the cement 30.
도 3은 임플란트용 차폐막(121)이 골 이식재(60)(이를 "뼈 이식재"라고도 한다)을 덮고 있는 것을 도시한 단면도이다.3 is a cross-sectional view showing that the implantable shielding membrane 121 covers the bone graft material 60 (also referred to as "bone graft material").
도 3을 참고하면, 임플란트 시술시 우선 환자의 잇몸을 절개한 후 그 속에 임플란트 포스트(1)를 치조골(B)에 삽입한다. 치조골(B)이 부족한 경우 부족한 치조골(B)에 각형 인공뼈를 이식하거나 분말형 인공뼈(골 이식재(60))를 삽입하여 치조골(B)이 증대되도록 하는 골유도 재생술(Guided Bone Regeneration; GBR)을 시술할 수 있다. 골 이식재(60)가 채워진 후에, 골 이식재(60)가 필요한 형태를 유지할 수 있도록 하며, 연조직 개입을 막고 골조직 유입을 유도하기 위해 임플란트용 차폐막(121)이 사용될 수 있다.Referring to FIG. 3, the implant post (1) is inserted into the alveolar bone (B) after dissecting the gum of the patient. In case of lack of alveolar bone (B) Grafted bone regeneration (GBR) to increase the alveolar bone (B) by implanting angular artificial bone into the insufficient alveolar bone (B) or inserting a powdered artificial bone (bone graft 60) ) Can be performed. After the bone graft material 60 is filled, to ensure that the bone graft material (60) to maintain the required shape, to prevent the soft tissue intervention and to induce the bone tissue implantation membrane 121 may be used.
상기와 같은 임플란트용 차폐막(121)은 다양한 재질의 다양한 형상으로 형성될 수 있다. 상기와 같은 임플란트용 차폐막(121)은 치조골(B)에 임플란트 포스트(1) 및 골 이식재(60)를 덮고, 골유도 재생술 후 골 조직에 흡수되는 흡수성 차폐막(121A) 및 흡수성 차폐막(121A)의 외측면에 노출되도록 결합되어 흡수성 차폐막(121A)의 형상을 유지시키는 비흡수성 차폐막(121B) 중 적어도 하나를 포함할 수 있다. Implant shield film 121 as described above may be formed in a variety of shapes of a variety of materials. The above-described implant shield membrane 121 covers the implant post 1 and the bone graft material 60 on the alveolar bone B, and the absorbent shield membrane 121A and the absorbent shield membrane 121A absorbed into the bone tissue after bone induction regeneration. It may include at least one of the non-absorbent shielding film 121B coupled to be exposed to the outer surface to maintain the shape of the absorbent shielding film 121A.
상기와 같은 흡수성 차폐막(121A)은 생체분해물질로 만들어져 일정기간 장벽(Barrier)의 기능을 수행한 뒤 분해되어 조직에 흡수되도록 만들어진 제품이다. 십자형 타입(Cross-linked Type)과 비 십자형 타입(Non-Cross-linked Type) 등으로 구분되며 최소 2주부터 최대 54주까지 흡수되어 추가적인 제거 술식을 필요로 하지 않는다. 흡수성 차폐막(121A)이 외부에 노출되거나 손상이 되더라도 장벽으로서의 역할을 수행해서 감염의 위험도가 낮은 편이다.As described above, the absorbent shielding film 121A is made of a biodegradable material and performs a function of a barrier for a certain period of time, and then is decomposed and absorbed into tissue. It is divided into cross-linked type and non-cross-linked type, and it is absorbed from minimum 2 weeks to maximum 54 weeks and does not require additional removal technique. Even if the absorbent shield 121A is exposed to the outside or damaged, it acts as a barrier and has a low risk of infection.
주로 콜라겐(Collagen), 폴리유산수지(Polyactic acid), 폴리 그라틱 산(Polyglactic acid) 등으로 만들어지는 흡수성 차폐막(121A)은 2차 수술이 필요 없으며, 상피세포의 이동을 막고, 공간을 형성해 선택적 세포 증식 및 골 재생을 유도한다. 또한 흡수성 차폐막(121A)는 탄성이 있어 상처에 가해지는 기계적 스트레스를 차단할 목적으로 사용된다.Absorbent shield (121A), which is mainly made of collagen, polylactic acid, and polyglactic acid, does not require secondary surgery, prevents the migration of epithelial cells, forms a space, and is selective. Induces cell proliferation and bone regeneration. In addition, the absorbent shielding film 121A is elastic and is used for the purpose of blocking mechanical stress applied to the wound.
예를 들면, 흡수성 차폐막(121A)는 콜라겐을 대표적으로 들 수 있는데 보통 동물의 힘줄(Tendon) 등에서 얻어진 콜라겐을 처리해서 만든다. 이와 같은 흡수성 차폐막(121A)의 경우 비흡수성 차폐막보다 골재생에 있어 다소 지연되는 것으로 알려졌으며 부작용이 비흡수성 차폐막(121B)보다 적고 안전성에서도 우수한 편이다.For example, the absorbent shielding film 121A may be representative of collagen, and is usually made by treating collagen obtained from an animal tendon or the like. Such an absorbent shielding membrane 121A is known to be somewhat delayed in bone regeneration than the non-absorbing shielding membrane, and has less side effects than the non-absorbing shielding membrane 121B and is excellent in safety.
하지만 흡수성 차폐막(121A)만을 단독으로 사용할 경우 비흡수성 차폐막(121B)에 비해 공간확보 능력이 다소 떨어지며 지지대로서의 효능이 작은 단점이 있다.However, when only the absorbent shielding film 121A is used alone, the space securing ability is somewhat lower than that of the non-absorbing shielding film 121B, and the effect as a support is small.
이에 비하여 티타늄(Ti)과 같은 금속 소재를 사용하는 비흡수성 차폐막(121B)은, 형태가 유지되어 지지대로서의 역할을 수행하여 세포가 증식되는 데 필요한 기간 확보가 용이하다는 점이 장점이다.On the other hand, the non-absorbent shielding film 121B using a metal material such as titanium (Ti) is advantageous in that it is easy to secure a period required for cell proliferation by maintaining its shape and serving as a support.
임플란트 차폐막(121)은 상기와 같이 형성되는 것 이외에도 골 성분으로 형성될 수 있다.The implant shield layer 121 may be formed of a bone component in addition to being formed as described above.
이하에서는 골 성분으로 형성되는 임플란트 차폐막(121)에 대해서 상세히 설명하기로 한다.Hereinafter, the implant shield layer 121 formed of the bone component will be described in detail.
도 4는 본 발명의 일 실시예에 따른 임플란트용 차폐막(200)을 나타내는 사시도이다. 도 5은 도 4에 도시된 임플란트용 차폐막(200)이 형성된 이종골을 보여주는 사시도이다.4 is a perspective view showing an implant shield membrane 200 according to an embodiment of the present invention. FIG. 5 is a perspective view illustrating a distal bone in which the shielding membrane 200 for the implant shown in FIG. 4 is formed.
도 4 및 도 5를 참고하면, 임플란트용 차폐막(200, 200A)은 골 성분인 바디부(210, 210A)를 구비할 수 있다. 골 성분은 동종골, 합성골, 및 이종골 중 어느 하나 또는 그 조합일 수 있다.4 and 5, the implantation shields 200 and 200A may include body parts 210 and 210A, which are bone components. The bone component may be any one or combination of allogeneic bone, synthetic bone, and heterologous bone.
구체적으로 동종골은 인간의 뼈를 의미한다. 동종골로 이루어진 바디부(210, 210A)는 환자 본인 또는 다른 사람의 뼈 일부를 깍아서 만들어질 수 있다. 예를 들면, 임플란트 포스트(미도시)가 장착될 치조골의 일부를 쉘(shell) 형태로 가공하여, 바디부(210, 210A)를 형성할 수 있다.Specifically, allogeneic bone refers to human bone. The body parts 210 and 210A made of allogeneic bone may be made by shaving a portion of a bone of the patient or another person. For example, a portion of the alveolar bone on which the implant post (not shown) is to be mounted may be processed into a shell to form body parts 210 and 210A.
상기와 같은 동종골은 이식재를 동결시키거나 동결건조, 탈회동결건조, 그리고 방사선 조사를 가한 형태로 항원성을 제거하여 사용할 수 있으며, 골형성에 필요한 기간이 길고 새로 생성되는 골량도 적지만 필요한 양을 아무 때나 사용할 수 있고 부가적 수술부위를 만들지 않는다는 장점이 있다.Allogeneic bone can be used to remove the antigenicity in the form of freezing the graft or freeze-drying, de-freeze-dried, and irradiated, and it takes a long period of bone formation and a small amount of newly produced bone, It can be used at any time and does not create additional surgical sites.
이러한 동종골의 종류로는 동결건조골 중 비탈회형태(Demineralized freeze dried bone allografts, DFDBA), 탈회형태(Freeze dried bone allografts, FDBA) 그리고 방사선 조사 해면골 형태(Irradiated cancellous bone,ICB)가 있다.The allogeneic bones include demineralized freeze dried bone allografts (DFDBA), freeze dried bone allografts (FDBA), and irradiated cancellous bone (ICB).
이종골은 소나 돼지 등의 동물의 뼈를 의미한다. 이러한 여러 과정을 거쳐 면역반을을 떨어뜨려 골전도 능력을 기대하는 이식재이며, 추가적인 수술부위를 만들지 않아도 되는 장점과 원하는 양만큼 충분히 사용할 수 있다는 장점이 있으나 흡수되고 치환되는데 오랜 시간이 걸리는 관계로 골유도 보다는 골전도의 기전으로 이해되는 것이 현재의 흐름이다. 이러한 이종골의 종류로는 Bio-Oss, ABM/P-15 및 BioCeraTM 등이 있다.Heterogol means bones of animals such as cattle or pigs. It is an implant that expects bone conduction ability by dropping immune plaque through various processes, and it does not need to make additional surgical site and it can be used as much as you want, but it takes a long time to absorb and replace. What is understood as the mechanism of bone conduction rather than induction is the current flow. Examples of such heterogenous bones include Bio-Oss, ABM / P-15 and BioCera ™.
또한, 합성골은 인공적으로 형성된 뼈를 의미한다. 합성골은 동물의 뼈인 이종골을 일부 성분으로 하여 다른 재질을 혼합하여 형성되거나, 골 성분을 대체할 수 있는 재질로 형성될 수 있다. 이러한 합성골은 실제 뼈가 아니라 인공적으로 합성해서 만든 뼈이기 때문에 다른 뼈이식재에 비해서 가장 질이 떨어지고 골형성에 필요한 기간이 길지만 저렴하다는 장점이 있다. 이때, 합성골은 non-porous hydroxyapatite(HA), hydroxyapatite cement, porous hydroxyapatite, beta tricalcium phosphate, polymethlymethacrylate(PMMA)와 hydroxyet-hylmethacrylate(HEMA) polymer, 그리고 bioactive glass 등이 임상에서 사용되고 있다. HA 그리고 PMMA와 HEMA polymer는 비흡수성이며, tricalcium phosphate와 bioactive는 흡수성이다. 이러한 합성골의 종류는 제3 인산칼슘, 경조직 개체 중합체 및 생활성 유리질 세라막 등이 있다. 이하에서는 설명의 편의를 위하여 바디부(210, 210A)는 이종골로 형성되는 경우를 중심으로 상세히 설명하기로 한다.In addition, synthetic bone means artificially formed bone. Synthetic bone may be formed by mixing different materials using a heterologous bone, which is an animal bone, as part of a component, or may be formed of a material that can substitute for a bone component. These synthetic bones are not actual bones, but are artificially synthesized bones, so compared to other bone grafts, the quality is inferior and the time required for bone formation is long but inexpensive. In this case, non-porous hydroxyapatite (HA), hydroxyapatite cement, porous hydroxyapatite, beta tricalcium phosphate, polymethlymethacrylate (PMMA) and hydroxyet-hylmethacrylate (HEMA) polymer, and bioactive glass are used in the clinical bone. HA and PMMA and HEMA polymers are nonabsorbent, tricalcium phosphate and bioactive are absorbent. Types of such synthetic bones include tricalcium phosphate, hard tissue individual polymers, and bioactive vitreous cera membranes. Hereinafter, for convenience of description, the body parts 210 and 210A will be described in detail with reference to the case where the bones are formed of dissimilar bones.
한편, 상기와 같은 바디부(210, 210A)의 두께는 치조골(미도시)의 손실부에 첨가되는 골 이식재(미도시)에 밀착하여 덮을 수 있도록 얇은 막 형태인 것이 바람직하다.On the other hand, the thickness of the body portion 210, 210A as described above is preferably in the form of a thin film so as to cover in close contact with the bone graft material (not shown) added to the loss of the alveolar bone (not shown).
상기와 같은 바디부(210, 210A)는 다양한 형태로 형성될 수 있다. 예를 들면, 바디부(210, 210A)는 유선형 또는 곡률지게 형성될 수 있다. 또한, 바디부(210, 210A)는 반구 형상, 구 형상, 타원 형상 등으로 형성될 수 있다. 바디부(210, 210A)는 상기의 경우 이외에도 플레이트 형태로 형성되는 것도 가능하다. 이때, 바디부(210, 210A)는 상기 치조골의 형태, 인접하는 치아의 배열 형태 등을 고려하여 다양한 형상으로 형성될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 바디부(210, 210A)는 일부가 굴곡지게 형성되는 경우를 중심으로 상세히 설명하기로 한다. The body parts 210 and 210A as described above may be formed in various forms. For example, the body parts 210 and 210A may be streamlined or curved. In addition, the body parts 210 and 210A may be formed in a hemispherical shape, a spherical shape, an elliptic shape, or the like. The body parts 210 and 210A may be formed in a plate shape in addition to the above cases. In this case, the body parts 210 and 210A may be formed in various shapes in consideration of the shape of the alveolar bone and the arrangement of adjacent teeth. However, hereinafter, for convenience of description, the body parts 210 and 210A will be described in detail with reference to a case in which a part is formed to be bent.
구체적으로 도 4(a)의 바디부(210)는 커버부(211)와, 커버부(211)로부터 절곡되어 형성되는 제1 절곡부(212)를 포함할 수 있다. 또한, 바디부(211)는 바디부(211)로부터 절곡되어 형성되며, 제1 절곡부(212)와 대향하도록 배치되는 제2 절곡부(213)를 포함할 수 있다. 이때, 커버부(211)는 상기 임플란트 포스트가 시술된 상기 골 이식재의 상부를 커버할 수 있으며, 제1 절곡부(211)는 상기 골 이식재의 측면 부분을 커버할 수 있다. 또한, 제2 절곡부(213)는 정상적인 상기 치조골에 걸치도록 할 수 있다.In detail, the body part 210 of FIG. 4A may include a cover part 211 and a first bent part 212 formed by being bent from the cover part 211. In addition, the body part 211 may be bent from the body part 211 and may include a second bent part 213 disposed to face the first bent part 212. In this case, the cover portion 211 may cover the upper portion of the bone graft material implanted with the implant post, the first bent portion 211 may cover the side portion of the bone graft material. In addition, the second bent portion 213 may extend to the normal alveolar bone.
즉, 제1 및 제2 절곡부(212, 213)는 서로 치열방향의 수직한 방향으로 배치될 수 있다. 구체적으로 제1 및 제2 절곡부(212, 213) 중 어느 하나는 상기 치조골을 중심으로 입술 방향에 배치될 수 있으며, 제1 및 제2 절곡부(212, 213) 중 다른 하나는 상기 치조골을 중심으로 혀 방향에 배치될 수 있다. 이때, 상기 치조골 및 상기 골 이식재는 제1 및 제2 절곡부(212, 213) 사이의 공간에 배치될 수 있으며, 제1 및 제2 절곡부(212, 213)는 상기 치조골 및 상기 골 이식재의 위치가 어긋나는 것을 방지할 수 있다.That is, the first and second bent portions 212 and 213 may be disposed in the vertical direction of the orthodontic direction. Specifically, any one of the first and second bent portions (212, 213) may be disposed in the lip direction around the alveolar bone, and the other one of the first and second bent portions (212, 213) to the alveolar bone It can be placed in the tongue direction as the center. At this time, the alveolar bone and the bone graft material may be disposed in the space between the first and second bent portions (212, 213), the first and second bent portions (212, 213) of the alveolar bone and the bone graft material The position shift can be prevented.
한편, 도 4(b)의 바디부(210A)는 커버부(211A)와 제1 절곡부(212A)를 포함할 수 있다. 이때, 커버부(211A)와 제1 절곡부(212A)는 상기에서 설명한 도 4의 (a)의 커버부(211A) 및 제1 절곡부(212A)와 동일 또는 유사할 수 있으므로 상세한 설명은 생략하기로 한다.Meanwhile, the body portion 210A of FIG. 4B may include a cover portion 211A and a first bent portion 212A. In this case, the cover portion 211A and the first bent portion 212A may be the same as or similar to the cover portion 211A and the first bent portion 212A of FIG. Let's do it.
상기와 같은 커버부(211A) 및 제1 절곡부(212A) 중 적어도 하나는 고정부재결합부(219A)를 구비할 수 있다. 나사나 쐐기 형태의 고정부재(미도시)는 고정부재결합부(219A)를 통해 임플란트용 차폐막(200A), 특히 차폐막의 어느 한 절곡부(예를 들어, 제1 절곡부(212A))를 치조골에 결합시킬 수 있다. 고정부재결합부(219A)는 바디부(210A)를 관통하도록 형성되는 홀 형태일 수 있다.At least one of the cover portion 211A and the first bent portion 212A as described above may include a fixing member coupling portion 219A. The fixing member (not shown) in the form of a screw or a wedge alveolar bone of the implant shield 200A, in particular any bent portion (eg, the first bent portion 212A), of the implant through the fixing member coupling portion 219A. Can be bound to The fixing member coupling portion 219A may have a hole shape formed to penetrate the body portion 210A.
상기와 같은 임플란트용 차폐막(200, 200A)을 이종골(70)로부터 가공하는 방법을 살펴보면 하기와 같다. 구체적으로 임플란트용 차폐막(200, 200A)은 해면조직(74) 또는 치밀골(76)로 가공될 수 있으며, 치밀골(76)과 해면조직(74) 모두 포함되도록 가공될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 임플란트용 차폐막(200, 200A)이 치밀골(76)로 가공되는 것을 중심으로 상세히 설명하기로 한다. Looking at the method of processing the implant shield membrane (200, 200A) from the distal bone 70 as described above are as follows. Specifically, the shielding membranes 200 and 200A for the implant may be processed into sponge tissue 74 or dense bone 76, and may be processed to include both dense bone 76 and sponge tissue 74. However, hereinafter, for convenience of description, the implantation shields 200 and 200A will be described in detail with reference to the processing of the dense bone 76.
구체적으로 임플란트 차폐막(200, 200A)은 이종골(70)의 외곽에 위치한 치밀골(76) 부위에서 필요한 형태로 가공되어 추출될 수 있다. 이때, 이종골(70)은 중앙에서부터 외각으로 갈수록 혈관부(72), 해면조직(74) 및 치밀골(76) 부위로 이루어져 있다. 치밀골(76) 부위는 골밀도가 다른 부위에 비해 높으므로 임플란트용 차폐막(200, 200A)은 치밀골(76) 부위에서 필요한 형태로 가공되어 추출될 수 있다. In more detail, the implant shielding membranes 200 and 200A may be processed and extracted in the required shape from the dense bone 76 located at the outer side of the distal bone 70. At this time, the heterogenous bone 70 is composed of a blood vessel portion 72, sponge tissue 74 and dense bone 76 from the center to the outer shell. Since the dense bone 76 area is higher than the other areas of bone density, the shielding membranes 200 and 200A for the implant may be processed and extracted in the required shape in the dense bone 76 area.
임플란트 차폐막(200, 200A)은 캐드캠(CAD/CAM) 또는 3D플린터를 통하여 이종골(70)에서 사용될 수 있는 형태로 가공되어 추출될 수 있다. 이때 캐드캠(CAD/CAM)은 또는 3D프린터는 이종골(70)의 외곽부에 위치한 치밀골(76)부위에서 적어도 일부분이 절곡되도록 형성되는 차폐막(200, 200A) 형태로 절삭되어 추출되도록 설계될 수 있다. The implant shields 200 and 200A may be processed and extracted in a form that can be used in the distal bone 70 through a CAD / CAM or 3D printer. In this case, the CAD / CAM may be designed to be cut and extracted in the form of a shielding film (200, 200A) formed to be bent at least a portion of the dense bone (76) located on the outer portion of the distal bone (70). have.
상기와 같이 임플란트 차폐막(200, 200A)을 이종골(70)로 가공하는 경우, 면역 반응 및 감염의 부작용이 발생할 수 있다. 이에 임플란트 차폐막(200, 200A)의 표면은 면역반응 제거 처리 또는 감염 차단 처리를 할 수 있다. 이러한 처리는 저온 또는고온 처리, 동결건조, 및 화학약품을 이용한 처리, 멸균처리 등 인체에 무해하도록 다양한 후처리를 할 수 있다. As described above, when the implant shielding membranes 200 and 200A are processed into the heterologous bone 70, side effects of immune response and infection may occur. The surface of the implant shield (200, 200A) may be subjected to immune response removal treatment or infection blocking treatment. This treatment can be a variety of post-treatment to be harmless to humans, such as low or high temperature treatment, lyophilization, treatment with chemicals, sterilization.
한편, 임플란트 차폐막(200, 200A)은 상기의 경우 이외에도 이종골(70)이나 합성골 성분을 압축 성형하여 가공할 수 있다. 뿐만 아니라, 차폐막은 다양한 형태로 가공될 수 있다.On the other hand, the implant shield membrane (200, 200A) can be processed by compression molding the different bone 70 or synthetic bone components in addition to the above case. In addition, the shielding film may be processed in various forms.
임플란트용 차폐막(200, 200A)은 바디부(210, 210A)에 형성되는 돌출부(220, 220A)를 구비할 수 있다. 이때, 돌출부(220, 220A)는 상기 임플란트 포스트를 향하도록 커버부(211, 211A)에 형성될 수 있다. 돌출부(220, 220A)에 대해서는 하기에서 상세히 설명하기로 한다. The implant shields 200 and 200A may include protrusions 220 and 220A formed on the body portions 210 and 210A. In this case, the protrusions 220 and 220A may be formed in the cover parts 211 and 211A to face the implant post. The protrusions 220 and 220A will be described in detail later.
도 15는 본 발명의 또다른 실시예에 따른 임플란트 차폐막을 나타내는 사시도이며, 도 16은 본 발명의 실시예에 따른 임플란트 차폐막의 관통홀의 형상을 나타내는 평면도이다.15 is a perspective view showing an implant shield according to another embodiment of the present invention, Figure 16 is a plan view showing the shape of the through-hole of the implant shield according to an embodiment of the present invention.
도 15를 참조하면, 임프란트 차폐막(100')은 도 4(a)에 도시된 임플란트 차폐막(100)의 돌출부(220) 대신, 관통홀(220')을 구비한다. Referring to FIG. 15, the implant shielding film 100 ′ includes a through hole 220 ′ instead of the protrusion 220 of the implant shielding film 100 illustrated in FIG. 4A.
관통홀(220')은 임플란트 포스트에 커버 스크류(또는 힐링 어버트먼트)가 통과할 수 있도록 하여 임플란트용 차폐막(200, 200A)이 임플란트 포스트에 고정되도록 할 수 있다. 관통홀은 도 15에 도시된 바와 같이 원형일 수 있다. 다만 관통홀은 이에 한정되지 않고 여러 형상을 가질 수 있다. 예를 들어, 도 16에 도시된 바와 같이, 원형홀(220'-1)과 바형 슬릿(220'-2)이 결합된 형태일 수 있다. 바형 슬릿(220'-2)은 원형홀(220'-1)의 지름보다 큰 포스트의 부분을 임플란트 차폐막이 통과하도록 하는 유연성을 제공할 수 있다. 후술하는 여러 실시예에 따른 임플란트 차폐막에 구비된 돌출부는 관통홀로 대체될 수 있다.The through hole 220 ′ may allow the cover screw (or healing abutment) to pass through the implant post so that the implant shields 200 and 200A may be fixed to the implant post. The through hole may be circular as shown in FIG. 15. However, the through hole is not limited thereto and may have various shapes. For example, as shown in FIG. 16, the circular hole 220'-1 and the bar-shaped slit 220'-2 may be combined. The bar-shaped slit 220'-2 may provide flexibility to allow the implant shield to pass through a portion of the post that is larger than the diameter of the circular hole 220'-1. Protrusions provided in the implant shielding film according to various embodiments to be described later may be replaced with through holes.
그 외에 구성요소는 도 4(a)와 동일하므로 동일한 부호가 지시하는 요소에 대한 설명은 생략한다.In addition, since the components are the same as in FIG. 4A, descriptions of the elements indicated by the same reference numerals will be omitted.
도 6은 도 4의 (a)에 도시된 임플란트용 차폐막 및 임플란트 포스트 시술이 적용된 부분을 보여주는 단면도이다.FIG. 6 is a cross-sectional view showing a portion to which an implant shielding membrane and an implant post procedure are shown in FIG.
도 6을 참고하면, 임플란트 시술 시 잇몸(미도시)을 절개한 후 치조골(B)에 임플란트 포스트(1)를 심을 수 있다. 이때, 임플란트 포스트(1)는 인터널형 임플란트 포스트 또는 익스터널형 임플란트 포스트를 포함할 수 있다. 다만, 이하에서는 설명의 편의를 위하여 임플란트 포스트(1)가 인터널형 임플란트 포스트를 포함하는 경우를 중심으로 상세히 설명하기로 한다. Referring to FIG. 6, the implant post 1 may be planted in the alveolar bone B after dissecting the gum (not shown) during the implant procedure. In this case, the implant post 1 may include an internal implant post or an external implant post. However, hereinafter, the implant post 1 will be described in detail with reference to a case in which the implant post 1 includes an internal implant post.
상기와 같이 임플란트 포스트(1)를 치조골(B)에 심는 경우, 치조골(B)은 환자의 상태에 따라 일부가 함몰되거나 소실된 상태일 수 있다. 이와 같이 소실된 부위에 임플란트 포스트(1)를 삽입하면, 포스트의 유지 고정력이 저하되며 심미 보철에 문제가 발생하며, 포스트의 수명에도 악영향을 미칠 수 있다.When planting the implant post 1 in the alveolar bone (B) as described above, the alveolar bone (B) may be in a state in which a portion is recessed or missing depending on the condition of the patient. When the implant post 1 is inserted into the missing portion as described above, the holding force of the post is lowered, a problem occurs in the aesthetic prosthesis, and may adversely affect the life of the post.
상기와 같은 문제를 방지하기 위하여 치조골(B) 일부가 함몰되거나 소실된 부분에 골 이식재(60)를 채울 수 있다. 이때, 골 이식재(60)는 일정 시간이 경과하여야 뼈로 대체될 수 있다. 상기와 같이 골 이식재(60)가 치조골(B)에 대체될 때까지 치조골(B) 일부와 골 이식재(60)의 외면에 임플란트용 차폐막(200)을 설치하여 골 이식재(60)의 형태를 유지시킬 수 있다. In order to prevent the above problems, the bone graft material 60 may be filled in a portion where the alveolar bone B is recessed or lost. At this time, the bone graft 60 may be replaced with bone only after a certain time passes. Maintaining the shape of the bone graft material 60 by installing the implant shield 200 on the outer surface of the alveolar bone B and the bone graft material 60 until the bone graft material 60 is replaced with the alveolar bone B as described above. You can.
구체적으로 상기와 같이 임플란트 포스트(1)를 치조골(B)에 시술하는 경우 골조직 결합부(10)는 치조골(B)에 삽입될 수 있다. 이때, 치관 연결부(20)의 적어도 일부분은 치조골(B)의 외부로 돌출될 수 있다.Specifically, when the implant post 1 is applied to the alveolar bone B, the bone tissue coupling part 10 may be inserted into the alveolar bone B. At this time, at least a portion of the crown connection portion 20 may protrude to the outside of the alveolar bone (B).
상기와 같은 시술이 완료되면, 임플란트 포스트(1)가 자리를 잡도록 일정 시간이 경과하여야 한다.When the above procedure is completed, a predetermined time must elapse to allow the implant post 1 to settle.
한편, 상기와 같인 임플란트 포스트(1)가 치조골(B)에 설치된 후 치조골(B)이 소실된 부분에 골 이식재(60)를 삽입할 수 있다. 이때, 골 이식재(60)가 삽입된 부분에는 골 이식재(60)가 이탈되거나 형상이 변하는 것을 방지하도록 상기에서 설명한 임플란트용 차폐막(200)을 설치할 수 있다. On the other hand, the implant post (1) as described above may be inserted into the bone graft material (60) in the alveolar bone (B) after the alveolar bone (B) is missing. At this time, the implant graft 60 may be installed in the portion where the bone graft material 60 is inserted or shielded membrane 200 for the implant described above to prevent the shape change.
구체적으로 임플란트용 차폐막(200)은 임플란트 포스트(1)의 상면 및 골 이식재(60)의 일부를 덮도록 배치될 수 있다. 이때, 커버부(211)는 상기에서 설명한 바와 같이 임플란트 포스트(1)의 상면에 배치되며, 제1 절곡부(212)는 골 이식재(60) 부분에 접촉하도록 배치될 수 있다. 또한, 제2 절곡부(213)는 제1 절곡부(212)와 반대 방향에서 치조골(B)의 일부와 접촉할 수 있다. 이때, 제1 절곡부(212)와 제2 절곡부(213)의 위치는 상기에 한정되는 것은 아니며 서로 반대로 배치되는 것도 가능하다. In detail, the implant shield 200 may be disposed to cover the upper surface of the implant post 1 and a part of the bone graft material 60. In this case, as described above, the cover part 211 may be disposed on the upper surface of the implant post 1, and the first bent part 212 may be disposed to contact the bone graft material 60. In addition, the second bent portion 213 may contact a portion of the alveolar bone B in a direction opposite to the first bent portion 212. In this case, the positions of the first bent portion 212 and the second bent portion 213 are not limited to the above, but may be disposed opposite to each other.
한편, 상기와 같이 바디부(210)가 설치되는 경우, 돌출부(220)는 치관 연결부(220)의 상기 암나사부에 삽입될 수 있다. 또는 임시볼트(150)가 상기 암나사부에 설치되는 경우 돌출부(220)는 임시볼트(150)의 오목부(153)에 삽입될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 치관 연결부(20)에 임시볼트(150)가 설치되고, 돌출부(220)는 오목부(153)에 삽입되는 경우를 중심으로 상세히 설명하기로 한다. On the other hand, when the body portion 210 is installed as described above, the protrusion 220 may be inserted into the female screw portion of the crown connection portion 220. Alternatively, when the temporary bolt 150 is installed in the female screw portion, the protrusion 220 may be inserted into the recess 153 of the temporary bolt 150. However, hereinafter, the temporary bolt 150 is installed in the crown connection portion 20 for convenience of description, and the protrusion 220 will be described in detail with reference to the case where it is inserted into the recess 153.
상기와 같은 돌출부(220)는 오목부(153)에 억지 끼움될 수 있다. 이때, 오목부(153)는 오목부(153)의 길이 방향과 수직한 오목부(153)의 단면이 정육각형 등의 정다각형인 다각기둥, 원기둥, 원뿔, 또는 반구 형상일 수 있다. 또한, 돌출부(220)는 원기둥, 원뿔, 반구 또는 단면이 정육각형 등과 같은 정다각형인 다각기둥 형상으로 형성될 수 있다. 이때, 돌출부(220)와 오목부(153)의 형상은 서로 상이하게 형성될 수 있다. 예를 들면, 오목부(153)이 다각기둥 형태로 형성되는 경우 돌출부(220)의 단면은 원기둥, 원뿔, 반구 형상으로 형성될 수 있다. 반면, 오목부(153)이 원기둥, 원뿔, 반구 형상으로 형성되는 경우, 돌출부(220)는 정다각기둥 형태로 형성될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 오목부(153)가 정다기둥 형태로 형성되고, 돌출부(220)는 원기둥 형태로 형성되는 경우를 중심으로 상세히 설명하기로 한다.The protrusion 220 as described above may be forcibly fitted into the recess 153. In this case, the recess 153 may have a polygonal pillar, a cylinder, a cone, or a hemispherical shape in which a cross section of the recess 153 perpendicular to the longitudinal direction of the recess 153 is a regular polygon such as a regular hexagon. In addition, the protrusion 220 may be formed in a cylinder, cone, hemisphere or polygonal polygonal shape of a regular polygon such as a regular hexagon. In this case, the shapes of the protrusion 220 and the recess 153 may be different from each other. For example, when the concave portion 153 is formed in a polygonal column shape, the cross section of the protrusion 220 may be formed in a cylinder, a cone, and a hemispherical shape. On the other hand, when the concave portion 153 is formed in a cylinder, cone, hemispherical shape, the protrusion 220 may be formed in a regular polygonal column shape. However, hereinafter, the concave portion 153 is formed in a regular pillar shape for convenience of description, and the protrusion 220 will be described in detail with reference to a case in which it is formed in a cylindrical shape.
상기와 같이 돌출부(220)와 오목부(153)가 억지 끼움되는 경우에도 돌출부(220)의 외면과 오목부(153)의 내면 사이에는 공간이 형성될 수 있다. 따라서 돌출부(220)와 오목부(153)의 형상이 상이함으로써 오목부(153)로부터 돌출부(220)를 원활하게 제거할 수 있다. Even when the protrusion 220 and the recess 153 are forcibly fitted as described above, a space may be formed between the outer surface of the protrusion 220 and the inner surface of the recess 153. Therefore, since the protrusions 220 and the recesses 153 have different shapes, the protrusions 220 may be smoothly removed from the recesses 153.
돌출부(220)가 오목부(153)에 적절한 억지 끼움이 되도록, 돌출부(220) 중 어느 한 단면의 지름은 오목부(153) 단면의 중심을 기준으로 상호 대향되는 내측단의 최단 이격거리 보다 크고, 오목부(153) 단면의 중심을 기준으로 상호 대향되는 내측단의 최장 이격거리 보다 작을 수 있다.The diameter of either cross section of the protrusions 220 is greater than the shortest separation distance of the inner ends opposed to each other with respect to the center of the cross section of the recesses 153 so that the protrusions 220 are appropriately fitted to the recesses 153. The center of the recess 153 may be smaller than the longest separation distance between the inner ends that face each other.
한편, 돌출부(220)가 임시볼트(150)의 오목부(153)에 억지끼운 상태에서 임플란트용 차폐막(200)을 회전시키는 경우, 임플란트용 차폐막(200)은 임시볼트(150)에 대하여 상대적인 원형 운동을 할 수 있다. 이에 의해, 임플란트용 차폐막(200)은 시술시 임플란트용 차폐막(200)의 위치 및 방향을 정한 후, 임플란트 포스트(1)에 수직으로 장착 가능하며, 방향에 오차가 있는 경우 간단하게 임플란트용 차폐막(200)을 회전시키는 동작으로 쉽게 그 오차를 보정할 수 있다.On the other hand, when the protrusion 220 rotates the implant shield 200 in a state in which the protrusion 220 is sandwiched in the recess 153 of the temporary bolt 150, the implant shield 200 is circular relative to the temporary bolt 150 You can exercise. As a result, the implant shield membrane 200 may be mounted vertically to the implant post 1 after determining the position and direction of the implant shield membrane 200 during the procedure, and if there is an error in the orientation, the implant shield membrane ( The operation of rotating 200 can easily correct the error.
상기와 같은 돌출부(220)는 바디부(210)와 동일한 재질 또는 유사한 재질로 형성될 수 있다. 예를 들면, 돌출부(220)는 동종골, 이종골 및 합성골 중 적어도 하나로 형성될 수 있다. 이때, 돌출부(220)는 바디부(210)를 형성하는 경우 일체로 형성될 수 있으며, 별도로 제작되어 바디부(210)에 연결되도록 결합하는 것도 가능하다. The protrusion 220 as described above may be formed of the same material as or similar to the body portion 210. For example, the protrusion 220 may be formed of at least one of allogeneic bone, xenograft, and synthetic bone. In this case, the protrusion 220 may be integrally formed when the body portion 210 is formed, or may be separately manufactured to be coupled to the body portion 210.
또한, 돌출부(220)는 바디부(210)와 완전히 상이한 재질로 형성될 수 있다. 예를 들면, 돌출부(220)는 티타늄과 같은 금속 재질 또는 레진이나 엔지니어링 플라스틱과 같은 플라스틱 재질로 형성될 수 있다. 돌출부는 금속과 플라스틱 재질이 혼합되어 형성될 수도 있다. 이때, 돌출부(220)는 바디부(210)와 별도로 제작되어 바디부(210)에 설치될 수 있다. 구체적으로 돌출부(220)는 금속 재질 또는 플라스틱 재질로 형성된 후 바디부(210)에 일부가 삽입되어 결합하거나 접착 물질을 통하여 바디부(210)에 고정되는 것도 가능하다. 이하에서는 설명의 편의를 위하여 돌출부(220)는 바디부(210)와 일체로 형성되는 경우를 중심으로 상세히 설명하기로 한다. In addition, the protrusion 220 may be formed of a material different from that of the body 210. For example, the protrusion 220 may be formed of a metal material such as titanium or a plastic material such as resin or engineering plastic. The protrusion may be formed by mixing a metal and a plastic material. In this case, the protrusion 220 may be manufactured separately from the body 210 and installed on the body 210. In more detail, the protrusion 220 may be formed of a metal material or a plastic material, and then a part of the protrusion 220 may be inserted into and coupled to the body 210 or may be fixed to the body 210 through an adhesive material. Hereinafter, the protrusion 220 will be described in detail with reference to a case in which the protrusion 220 is integrally formed with the body 210.
상기와 같이 돌출부(220)를 임시볼트(150)의 오목부(153)에 설치한 후 시간이 경과하면, 골 이식재(60)가 치조골(B)에 완전히 접합될 수 있다. As time elapses after the protrusion 220 is installed in the recess 153 of the temporary bolt 150, the bone graft material 60 may be completely bonded to the alveolar bone B.
따라서 임플란트용 차폐막(200)은 골 이식재(60)의 형태를 유지함으로써 골 이식재(60)가 치조골(B)에 안전하게 안착하도록 도와줄 수 있다. 뿐만 아니라 임플란트용 차폐막(200)은 골 성분으로 형성됨으로써 골 이식재(60)가 치조골(B)에 단시간내에 안착하도록 도와줄 수 있다. Therefore, the implant shield 200 may help to securely secure the bone graft (60) to the alveolar bone (B) by maintaining the shape of the bone graft (60). In addition, the implant shield membrane 200 may be formed of a bone component to help the bone graft material 60 to rest in the alveolar bone B in a short time.
도 7은 도 4의 (b)에 도시된 임플란트용 차폐막(200A) 및 임플란트 포스트(1) 시술이 적용된 부분을 보여주는 단면도이다. FIG. 7 is a cross-sectional view showing a portion to which the implant shielding membrane 200A and the implant post 1 procedure shown in FIG. 4B are applied.
도 7을 참고하면, 임플란트 시술 시 임플란트용 차폐막(200A)을 사용하여 골 이식재(60)의 형상을 유지시킬 수 있다. 이때, 임플란트용 차폐막(200A)은 상기 도 6에서 설명한 바와 같이 임플란트 포스트(1), 골 이식재(B), 치조골(60) 일부를 감싸도록 설치됨으로써 골 이식재(60)를 지지할 수 있다. 이때, 돌출부(220A)는 임시볼트(150)의 오목부(153)에 삽입되도록 설치될 수 있으며, 커버부(211A)는 임플란트 포스트(1)의 상면을 덮도록 설치될 수 있다. 또한, 제1 절곡부(212A)는 골 이식재(60) 부분을 덮도록 설치될 수 있다. 상기와 같이 임플란트 차폐막(200A)이 설치되는 경우 외부의 충격 또는 내부의 골 이식재(60)의 유동에 따라서 임플란트 차폐막(200A)이 움직일 수 있다. Referring to FIG. 7, the shape of the bone graft material 60 may be maintained using the implant shield 200A during the implant procedure. In this case, the implant shield 200A may support the bone graft material 60 by being installed to cover a portion of the implant post 1, the bone graft material B, and the alveolar bone 60 as described above with reference to FIG. 6. At this time, the protrusion 220A may be installed to be inserted into the recess 153 of the temporary bolt 150, the cover portion 211A may be installed to cover the upper surface of the implant post (1). In addition, the first bent portion 212A may be installed to cover the portion of the bone graft material (60). When the implant shield 200A is installed as described above, the implant shield 200A may move according to an external impact or flow of the bone implant 60 inside.
임플란트 차폐막(200A)의 움직임을 방지하기 위하여 고정부재(300)를 고정부재결합부(219A)에 결합할 수 있다. 구체적으로 상기와 같이 바디부(210A)가 배치된 후 고정부재결합부(219A)에 고정부재(300)를 결합하면, 고정부재(300)는 바디부(210A)를 관통하여 골 이식재(60) 부분으로 삽입될 수 있다. 즉, 고정부재(300)는 제1 절곡부(212A)를 골 이식재(60) 부분에 완전히 밀착시켜 골 이식재(60)가 제1 절곡부(212A) 측으로 이동하는 것을 방지할 수 있다. 이때, 고정부재(300)는 볼트, 나사, 핀 등과 같은 형태로 형성될 수 있다. In order to prevent the movement of the implant shield 200A, the fixing member 300 may be coupled to the fixing member coupling part 219A. Specifically, after the body portion 210A is disposed as described above, when the fixing member 300 is coupled to the fixing member coupling portion 219A, the fixing member 300 penetrates through the body portion 210A to allow the bone graft material 60 to form. It can be inserted into the part. That is, the fixing member 300 may prevent the bone graft material 60 from moving to the first bent portion 212A by completely contacting the first bent portion 212A to the bone graft material 60. At this time, the fixing member 300 may be formed in the form of bolts, screws, pins and the like.
따라서 임플란트 차폐막(200A)은 골 이식재(60)가 단시간내에 안착하도록 도와줄 수 있다. 뿐만 아니라 임플란트 차폐막(200A)은 고정부재(300)를 통하여 바디부(210A)를 치조골(B) 및 골 이식재(60) 중 적어도 하나에 고정시킴으로써 골 이식재(60)의 형상을 유지시킬 수 있다. Therefore, the implant shield 200A may help the bone graft 60 to settle in a short time. In addition, the implant shield membrane 200A may maintain the shape of the bone graft material 60 by fixing the body portion 210A to at least one of the alveolar bone B and the bone graft material 60 through the fixing member 300.
도 8은 본 발명의 다른 실시예에 따른 임플란트용 차폐막(200C)을 보여주는 사시도이다.8 is a perspective view showing an implant shield (200C) according to another embodiment of the present invention.
도 8을 참조하면, 임플란트용 차폐막(200C)은 반구 형상으로 형성되는 바디부(210C)를 포함할 수 있다. 이때, 바디부(210C)의 내부에는 공간이 형성될 수 있다. 상기와 같은 바디부(210C)의 내부 공간에는 임플란트 포스트(미도시) 및 골 이식재(미도시) 중 적어도 하나를 위치시켜 커버할 수 있다. 또한, 바디부(210C)는 골 성분으로 형성될 수 있다. 이때, 골 성분은 상기에서 설명한 바와 동일 또는 유사하게 형성될 수 있으므로 상세한 설명은 생략하기로 한다. Referring to FIG. 8, the shielding film 200C for the implant may include a body portion 210C formed in a hemispherical shape. At this time, a space may be formed inside the body portion 210C. At least one of an implant post (not shown) and a bone graft material (not shown) may be disposed and covered in an internal space of the body portion 210C as described above. In addition, the body portion 210C may be formed of a bone component. In this case, since the bone component may be formed in the same or similar to that described above, a detailed description thereof will be omitted.
임플란트 차폐막(200C)은 상기에서 설명한 바와 같이 바디부(210C) 내부 공간으로 형성되는 돌출부(220C)를 포함할 수 있다. 이때, 돌출부(220C)는 상기에서 설명한 바와 같이 임플란트 시술 시 임플란트 차폐막(200C)의 위치가 벗어나는 것을 방지할 수 있다. 이때, 돌출부(220C)는 선택적으로 바디부(210C)에 형성되거나 형성되지 않을 수 있으며, 이하에서는 설명의 편의를 위하여 돌출부(220C)가 바디부(210C) 내부의 중앙 부분에 형성되는 경우를 중심으로 상세히 설명하기로 한다. As described above, the implant shield layer 200C may include a protrusion 220C formed in an internal space of the body portion 210C. In this case, as described above, the protrusion 220C may prevent the position of the implant shielding film 200C from being deviated during the implant procedure. In this case, the protrusion 220C may be selectively formed or not formed in the body portion 210C, and hereinafter, the protrusion 220C is formed at the central portion inside the body portion 210C for convenience of description. This will be described in detail.
한편, 상기와 같은 임플란트 차폐막(200C)은 상기 골 이식재를 시술 한 후 상기 임플란트 포스트 및 상기 골 이식재 중 적어도 하나를 커버하도록 설치될 수 있다. 이때, 상기 임플란트 포스트 및 상기 골 이식재 중 적어도 하나는 바디부(210C)의 내부에 삽입되어 상기 골 이식재의 경화가 완료될 때까지 상기 골 이식재의 형상 변화를 저감시킬 수 있다. Meanwhile, the implant shield membrane 200C as described above may be installed to cover at least one of the implant post and the bone graft material after the bone graft material. In this case, at least one of the implant post and the bone graft material may be inserted into the body portion 210C to reduce the shape change of the bone graft material until hardening of the bone graft material is completed.
또한, 상기와 같이 바디부(210C)가 설치되는 경우, 돌출부(220C)는 상기 임플란트 포스트에 결합하여 바디부(210C)를 고정시킬 수 있다. 특히 돌출부(220C)가 상기 임플란트 포스트에 결합하는 방법 및 구조는 상기에서 상세히 설명하였으므로 상세한 설명은 생략하기로 한다. In addition, when the body portion 210C is installed as described above, the protrusion 220C may be coupled to the implant post to fix the body portion 210C. In particular, the method and structure in which the protrusion 220C is coupled to the implant post has been described in detail above, and thus a detailed description thereof will be omitted.
따라서 임플란트 차폐막(200C)은 다양한 형태로 가공되어 상기 골 이식재의 양생을 보조할 수 있다. 뿐만 아니라 임플란트 차폐막(220C)은 골 성분으로 형성됨으로써 시술 시 발생하는 부작용을 최소화할 수 있을 뿐만 아니라 상기 골 이식재의 양생 시간을 단축시킬 수 있다. Therefore, the implant shielding membrane 200C may be processed in various forms to assist in curing the bone graft material. In addition, the implant shield (220C) is formed of a bone component can minimize the side effects caused during the procedure as well as shorten the curing time of the bone graft material.
도 9는 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막(200D)을 보여주는 사시도이다.9 is a perspective view illustrating a shield 200D for an implant according to another embodiment of the present invention.
도 9를 참조하면, 임플란트용 차폐막(200D)은 내부에 공간이 형성되며, 상기 공간이 개방되도록 개구부(218D)를 구비하는 바디부(210D)를 포함할 수 있다. 이때, 바디부(210D)는 골 성분으로 형성될 수 있으며, 다양한 형태로 형성될 수 있다. 예를 들면, 바디부(210D)는 다각기둥 형태로 형성될 수 있으며, 반원기둥 형태, 원뿔 형태, 쐐기 형태 등으로 형성될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 바디부(210D)는 사각기둥 형태로 형성되는 경우를 중심으로 상세히 설명하기로 한다. Referring to FIG. 9, the shielding film 200D for the implant may include a space formed therein, and may include a body portion 210D having an opening 218D to open the space. At this time, the body portion 210D may be formed of a bone component, and may be formed in various forms. For example, the body portion 210D may be formed in a polygonal column shape, and may be formed in a semi-cylindrical shape, a cone shape, a wedge shape, or the like. However, hereinafter, the body portion 210D will be described in detail with reference to a case where the body portion 210D is formed in a square pillar shape for convenience of description.
상기와 같은 바디부(210D)는 커버부(211D)와 절곡부(212D)를 구비할 수 있다. 이때, 절곡부(212D)는 커버부(211D)로부터 절곡되어 연결될 수 있다. 또한, 절곡부(212D)는 커버부(211D)의 외면을 완전히 깜싸도록 커버부(211D)와 연결될 수 있다.The body portion 210D as described above may include a cover portion 211D and a bent portion 212D. In this case, the bent portion 212D may be bent and connected to the cover portion 211D. In addition, the bent portion 212D may be connected to the cover portion 211D to completely cover the outer surface of the cover portion 211D.
바디부(210D)는 상기와 같이 형성됨으로써 커버부(211D)와 대향되는 면에 개구부(218D)를 구비할 수 있다. 특히 바디부(210D)는 커버부(211D) 및 절곡부(212D) 사이에 공간이 형성되어 임플란트 포스트(미도시) 및 골 이식재(미도시) 중 적어도 하나가 내부에 삽입될 수 있다.The body portion 210D may be formed as described above, and may include an opening 218D on a surface of the body portion 210D that faces the cover portion 211D. In particular, the body portion 210D may have a space formed between the cover portion 211D and the bent portion 212D so that at least one of an implant post (not shown) and a bone graft material (not shown) may be inserted therein.
임플란트용 차폐막(200D)은 바디부(210D)로부터 돌출되어 형성되는 돌출부(220D)를 포함할 수 있다. 돌출부(220D)는 커버부(211D)에 형성될 수 있다. 이때, 돌출부(220D)는 상기에서 설명한 것과 동일 또는 유사하므로 상세한 설명은 생략하기로 한다. The implant shield 200D may include a protrusion 220D protruding from the body portion 210D. The protrusion 220D may be formed on the cover 211D. In this case, since the protrusion 220D is the same as or similar to that described above, a detailed description thereof will be omitted.
상기 임플란트 포스트를 설치한 후 상기와 같이 형성되는 임플란트용 차폐막(200D)은 시술 시 상기 치조골에 설치될 수 있다. 이때, 바디부(210D) 내부의 공간에는 적어도 하나 이상의 상기 임플란트 포스트가 삽입될 수 있다. After the implant post is installed, the implant shield membrane 200D formed as described above may be installed on the alveolar bone during the procedure. In this case, at least one implant post may be inserted into a space inside the body 210D.
상기와 같이 바디부(210D)가 설치되는 경우 절곡부(212D)의 일부는 상기 치조골과 상기 골 이식재를 지지하고, 절곡부(212D)의 다른 일부는 상기 치졸골 및 골 이식재 중 적어도 하나에 삽입되도록 설치될 수 있다. 이때, 돌출부(220D)는 상기에서 설명한 바와 같이 임시볼트(미도시)의 오목부(미도시)에 삽입되도록 설치되어 바디부(210D)를 지지할 수 있다. When the body portion 210D is installed as described above, a portion of the bent portion 212D supports the alveolar bone and the bone graft material, and another portion of the bent portion 212D is inserted into at least one of the plaque and bone graft material. Can be installed as possible. In this case, the protrusion 220D may be installed to be inserted into the recess (not shown) of the temporary bolt (not shown) to support the body portion 210D as described above.
본 실시예에 따른 임플란트용 차폐막(200D)은 임플란트 시술 시 별도로 제거할 필요가 없으므로 부가적인 이차 수술이 필요 없다. Implant shielding film 200D according to the present embodiment does not need to be removed separately during implantation, so no additional secondary surgery is required.
도 10은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막(200E)을 보여주는 사시도이다.10 is a perspective view showing an implant shield (200E) according to another embodiment of the present invention.
도 10를 참고하면, 임플란트용 차폐막(200E)은 내부에 공간이 형성되는 바디부(210E)를 포함할 수 있다. 이때, 바디부(210E)는 골 성분으로 형성될 수 있으며, 커버부(211E)와, 커버부(211E)로부터 절곡되어 형성되는 절곡부(212E)를 구비할 수 있다. 특히 절곡부(212E)는 커버부(211E)의 외면을 감싸도록 배치될 수 있으며, 커버부(211E)와 절곡부(212E)는 내부에 공간을 형성할 수 있다. Referring to FIG. 10, the implant shield film 200E may include a body portion 210E having a space formed therein. In this case, the body portion 210E may be formed of a bone component, and may include a cover portion 211E and a bent portion 212E formed by bending from the cover portion 211E. In particular, the bent portion 212E may be disposed to surround the outer surface of the cover portion 211E, and the cover portion 211E and the bent portion 212E may form a space therein.
상기와 같이 형성되는 커버부(211E)와 절곡부(212E)는 치열에 대응되도록 곡률반경을 갖는 곡면으로 형성될 수 있다. 이때, 커버부(211E)의 곡률반경과 절곡부(212E)의 곡률반경은 일정하게 형성될 수 있으며, 복수개 구비되도록 형성될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 커버부(211E)의 곡률반경 및 절곡부(212E)의 곡률반경은 일정하게 형성되는 경우를 중심으로 상세히 설명하기로 한다. 특히 커버부(211E) 및 절곡부(212E)는 각각 부채꼴 형태로 형성되는 경우를 중심으로 상세히 설명하기로 한다. Cover portion 211E and the bent portion 212E formed as described above may be formed in a curved surface having a radius of curvature to correspond to the teeth. At this time, the radius of curvature of the cover portion 211E and the radius of curvature of the bent portion 212E may be formed to be constant, it may be formed to be provided in plurality. However, hereinafter, the radius of curvature of the cover portion 211E and the radius of curvature of the bent portion 212E will be described in detail with reference to a case where the shape is constant. In particular, the cover portion 211E and the bent portion 212E will be described in detail with a focus on the case each formed in a fan shape.
바디부(210E)는 임플란트 포스트(미도시)에 결합하는 어버트먼트(미도시)가 결합하는 결합부(290E)를 구비할 수 있다. 이때, 결합부(290E)는 홀이나 홈 형태로 형성될 수 있으며, 특히 결합부(290E)는 커버부(211E)를 관통하도록 형성될 수 있다. 이하에서는 설명의 편의를 위하여 결합부(290E)가 커버부(211E)를 관통하는 홀 형태인 경우를 중심으로 상세히 설명하기로 한다. The body portion 210E may include a coupling portion 290E coupled to an abutment (not shown) coupled to an implant post (not shown). In this case, the coupling part 290E may be formed in a hole or groove shape, and in particular, the coupling part 290E may be formed to penetrate the cover part 211E. Hereinafter, for convenience of description, the coupling part 290E will be described in detail with reference to a case of a hole shape passing through the cover part 211E.
한편, 상기와 같이 형성되는 임플란트용 차폐막(200E)은 여러 개의 임플란트를 동시에 시술할 때 적합할 수 있다. 아울러 임플란트용 차폐막(200E)은 전부 발치된 치아의 임플란트 시술시 사용될 수 있다. 구체적으로 바디부(210E) 내부에는 적어도 한 개 이상의 상기 임플란트 포스트가 배치될 수 있다. On the other hand, the implant shield film 200E formed as described above may be suitable when simultaneously performing a plurality of implants. In addition, the implant shield (200E) can be used during the implantation procedure of the tooth extracted entirely. Specifically, at least one implant post may be disposed in the body portion 210E.
우선 상기와 같이 형성된는 임플란트용 차폐막(200E)은 환자의 구강 구조 즉, 치조골(미도시)의 형태, 배열 등을 고려하여 제작될 수 있다. 특히 상기 임플란트 포스트를 설치한 후 상기 치조골에 골 이식재(미도시)를 배치하고, 임플란트용 차폐막(200E)의 바디부(210E)는 상기 치조골 및 골 이식재 중 적어도 하나를 감싸도록 배치될 수 있다. First, the implanted shield film 200E formed as described above may be manufactured in consideration of the oral structure of the patient, that is, the shape and arrangement of the alveolar bone (not shown). In particular, after installing the implant post, a bone graft material (not shown) is disposed on the alveolar bone, and the body portion 210E of the shield 200E for the implant may be disposed to surround at least one of the alveolar bone and the bone graft material.
이때, 커버부(211E)에 형성되는 결합부(290E)는 미리 식재될 상기 임플란트 포스트의 위치를 고려하여 형성될 수 있으며, 치관 결합부(미도시)에 대응되도록 형성될 수 있다. At this time, the coupling portion 290E formed on the cover portion 211E may be formed in consideration of the position of the implant post to be planted in advance, and may be formed to correspond to the crown coupling portion (not shown).
상기와 같이 임플란트용 차폐막(200E)이 배치되는 경우 임플란트 차폐막(200E)의 설치 후 상기 결합부에 임시볼트(미도시)를 삽입하여 상기 치관 결합부에 형성되는 암나사부(미도시) 및 삽입홈(미도시)을 차폐할 수 있다. When the implant shield membrane 200E is disposed as described above, after the installation of the implant shield membrane 200E, a temporary bolt (not shown) is inserted into the coupling portion to form a female screw portion (not shown) and an insertion groove formed in the crown coupling portion. (Not shown) can be shielded.
따라서 임플란트 포스트(200E)는 바디부(210E)를 통하여 상기 골 이식재를 지지함으로써 상기 골 이식재의 형태 변화를 줄일 수 있다. 또한, 임플란트 포스트(200E)는 상기 골 이식재의 형태를 미리 예측할 수 있으므로 시술자가 뼈 형성량을 쉽게 예측할 수 있다.Therefore, the implant post 200E may reduce the shape change of the bone graft by supporting the bone graft through the body portion 210E. In addition, since the implant post 200E can predict the shape of the bone graft in advance, the operator can easily predict the amount of bone formation.
도 11은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막(200F)을 보여주는 사시도이다. 도 12는 도 11의 A-A선 및 B-B선을 따라 취한 단면도이다.11 is a perspective view showing an implant shield (200F) according to another embodiment of the present invention. 12 is a cross-sectional view taken along line A-A and line B-B of FIG.
도 11 및 도 12를 참고하면, 임플란트용 차폐막(200F)은 골 성분으로 형성되는 바디부(210F)와, 바디부(210F)에 형성되는 돌출부(220F)를 포함할 수 있다. 이때, 바디부(210F)는 커버부(211F) 및 커버부(211F)로부터 절곡되어 형성되는 절곡부(212F)를 구비할 수 있다. Referring to FIGS. 11 and 12, the implant shield film 200F may include a body portion 210F formed of a bone component and a protrusion 220F formed on the body portion 210F. At this time, the body portion 210F may include a cover portion 211F and a bent portion 212F formed by being bent from the cover portion 211F.
상기와 같은 커버부(211F)와 절곡부(212F)는 서로 연결됨으로써 내부에 공간을 형성할 수 있다. 특히 상기와 같은 내부 공간에는 치조골(미도시) 및 골 이식재(미도시) 중 적어도 하나가 삽입될 수 있다. The cover portion 211F and the bent portion 212F as described above may be connected to each other to form a space therein. In particular, at least one of the alveolar bone (not shown) and bone graft material (not shown) may be inserted into the internal space.
커버부(211F) 및 절곡부(212F)는 각각 곡률반경을 갖는 곡면으로 형성될 수 있다. 이때, 커버부(211F) 및 절곡부(212)는 각각 길이 방향으로 곡면으로 형성될 수 있다. 또한, 커버부(211F)는 절곡부(212)의 높이 방향의 곡면으로 형성될 수 있다. The cover portion 211F and the bend portion 212F may each be formed as a curved surface having a radius of curvature. At this time, the cover portion 211F and the bent portion 212 may be formed in a curved surface in the longitudinal direction, respectively. In addition, the cover portion 211F may be formed as a curved surface in the height direction of the bent portion 212.
상기와 같은 길이 방향의 커버부(211F) 곡률반경 및 절곡부(212F) 곡률반경은 일정할 수 있으며, 서로 다른 복수개일 수 있다. 특히 커버부(211F)와 절곡부(212F)는 치열에 대응되는 곡면으로 형성될 수 있다. The radius of curvature of the cover portion 211F and the radius of curvature of the bent portion 212F in the longitudinal direction as described above may be constant, and may be different from each other. In particular, the cover portion 211F and the bent portion 212F may be formed in a curved surface corresponding to the teeth.
상기와 같은 바디부(210F)의 단면은 다양하게 형성될 수 있다. 예를 들면, 바디부(210F)의 단면은 'ㄷ'자 또는 말발굽과 같은 'U'자 형태의 아치형일 수 있다. 이때, 바디부(210F)의 단면 형상은 상기에 한정되지 않으며 치열 또는 상기 치조골의 형상, 상기 골 이식재의 배치 형태, 상기 골 이식재로 인한 전체 형상 등에 따라 다양하게 형성될 수 있다.(도 12의 (a) 및 (b) 참고)The cross section of the body portion 210F as described above may be variously formed. For example, the cross section of the body portion 210F may be an arch of a 'U' shape, such as 'c' or horseshoe. At this time, the cross-sectional shape of the body portion 210F is not limited to the above, and may be variously formed according to the shape of the teeth or the alveolar bone, the arrangement form of the bone graft material, the overall shape due to the bone graft material, and the like. (a) and (b))
상기와 같은 커버부(211F)에는 외부로부터 체결 기구가 삽입되는 결합부(290F)가 형성될 수 있다. 이때, 결합부(290F)는 커버부(211F)에 형성될 수 있다. The cover portion 211F may be provided with a coupling portion 290F into which the fastening mechanism is inserted from the outside. In this case, the coupling part 290F may be formed in the cover part 211F.
결합부(290F)는 상기에서 설명한 것과 동일 또는 유사하게 형성될 수 있다. 이때, 결합부(290F)는 커버부(211F)를 관통하도록 형성될 수 있으며, 커버부(211F) 및 돌출부(212F)를 관통하도록 형성될 수 있다. 이때, 결합부(290F)에는 임시볼트(미도시) 또는 임플란트 포스트(미도시)에 결합하는 어버트먼트(미도시), 치관 결합용 볼트(미도시) 등이 삽입되어 고정될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 결합부(290F)는 커버부(211F)만을 관통하도록 형성되는 경우를 중심으로 상세히 설명하기로 한다. 상기와 같이 결합부(290F)가 형성되는 경우 결합부(290F) 및 돌출부(220F)는 서로 교번하도록 배치될 수 있다. Coupling portion 290F may be formed the same as or similar to that described above. In this case, the coupling part 290F may be formed to penetrate the cover part 211F, and may be formed to penetrate the cover part 211F and the protrusion part 212F. At this time, the coupling portion 290F may be fixed by inserting an abutment (not shown), a crown coupling bolt (not shown), or the like coupled to a temporary bolt (not shown) or an implant post (not shown). However, hereinafter, for convenience of description, the coupling part 290F will be described in detail with reference to the case where the cover part 211F is formed to penetrate only. When the coupling portion 290F is formed as described above, the coupling portion 290F and the protrusion 220F may be disposed to alternate with each other.
한편, 상기와 같이 형성되는 임플란트용 차폐막(200F)은 상기 골 이식재를 설치한 경우 골 이식재의 형상을 유지시킬 수 있다. 이때, 임플란트용 차페막(200F)은 상기 임플란트 포스트에 돌출부(220F)가 결합됨으로써 고정될 수 있다. On the other hand, the implant shield membrane (200F) formed as described above can maintain the shape of the bone graft material when the bone graft material is installed. In this case, the shield 200F for the implant may be fixed by coupling the protrusion 220F to the implant post.
상기 골 이식재의 경화가 완료되면, 상기 치관 결합용 볼트를 결합부(290F)에 삽입하여 상기 어버트먼트를 고정시킬 수 있다. 이때 상기 어버트먼트의 고정 방법은 상기에 한정되는 것은 아니며, 상기 치관 결합용 볼트를 결합부(290F)를 통하여 상기 치관 연결부의 상기 암나사부에 고정시키는 것도 가능하다. When the hardening of the bone graft is completed, the abutment bolt may be inserted into the coupling part 290F to fix the abutment. At this time, the fixing method of the abutment is not limited to the above, it is also possible to fix the crown coupling bolt through the coupling portion 290F to the female screw portion of the crown connection portion.
따라서 임플란트용 차폐막(200F)은 골 성분으로 형성되므로 치아의 손상부위가 매우 적어 골 생성 부위가 상대적으로 작은 경우 별도로 흡수성 차폐막 및 비흡수성 차폐막의 기능상 성분으로 분리 제작하지 않고, 골 성분으로부터 필요한 형상으로 제작되어 시술에 직접 이용되는 바, 골 생성부에 대한 흡수성 및 차폐성과 유지성이 향상되는 이점이 있다.Therefore, since the implant shielding membrane 200F is formed of a bone component, the damage portion of the tooth is very small, and thus the bone formation site is relatively small. Bar is manufactured and used directly in the procedure, there is an advantage that the absorption and shielding properties and retention properties for the bone generating part is improved.
도 13은 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막(200G)의 사시도이다.13 is a perspective view of an implant shield (200G) according to another embodiment of the present invention.
도 13을 참고하면, 임플란트용 차폐막(200G)은 바디부(210G) 및 돌출부(220G)를 포함할 수 있다. 바디부(210G)는 커버부(211G)와 절곡부(미표기)를 구비할 수 있다. 이때, 바디부(210G)는 상기 도 4 내지 도 10에 도시된 것과 동일 또는 유사하게 형성될 수 있다. 또한, 바디부(210G)는 상기에 한정되지 않으며, 골 이식재(미도시)의 형상을 유지할 수 있는 모든 형상을 포함할 수 있다. 다만, 이하에서는 설명의 편의를 위하여 바디부(210G)가 상기 도 4의 (a)에 도시된 것과 동일 또는 유사하게 형성되는 경우를 중심으로 상세히 설명하기로 한다. Referring to FIG. 13, the shielding film 200G for the implant may include a body portion 210G and a protrusion 220G. The body portion 210G may include a cover portion 211G and a bent portion (not shown). In this case, the body portion 210G may be formed the same as or similar to that shown in FIGS. 4 to 10. In addition, the body portion 210G is not limited to the above, and may include any shape capable of maintaining the shape of a bone graft material (not shown). However, in the following description, the body portion 210G will be described in detail with reference to a case in which the body portion 210G is formed the same as or similar to that shown in FIG.
특히 상기와 같은 바디부(210G)는 커버부(211G), 제1 절곡부(212G) 및 제2 절곡부(213G)를 구비할 수 있다. 이때, 제1 절곡부(212G) 및 제2 절곡부(213G)는 커버부(211G)로부터 연장되어 형성되며, 커버부(211G)로부터 절곡되어 형성될 수 있다. In particular, the body portion 210G as described above may include a cover portion 211G, a first bent portion 212G, and a second bent portion 213G. In this case, the first bent part 212G and the second bent part 213G may be formed to extend from the cover part 211G and be bent from the cover part 211G.
한편, 임플란트용 차폐막(200G)은 바디부(210G)에 설치되는 패드부(240G)를 포함할 수 있다. 이때, 패드부(240G)는 커버부(211G), 제1 절곡부(212G) 및 제2 절곡부(213G) 중 적어도 하나에 설치될 수 있다. 특히 패드부(240G)는 치조골(미도시)의 일부가 소실된 부분에 배치되도록 바디부(210G)에 설치될 수 있다. Meanwhile, the implant shielding film 200G may include a pad part 240G installed in the body part 210G. In this case, the pad part 240G may be installed on at least one of the cover part 211G, the first bent part 212G, and the second bent part 213G. In particular, the pad portion 240G may be installed in the body portion 210G so that a portion of the alveolar bone (not shown) is disposed.
패드부(240G)는 다양한 형태로 형성될 수 있다. 구체적으로 패드부(240G)는 상기 치조골이 탈루된 부분의 형상에 대응되도록 형성될 수 있다. 예를 들면, 패드부(240G)는 직사각기둥 형태 일 수 있으며, 원뿔, 타원형의 패드 등 다양하게 형성될 수 있다. The pad part 240G may be formed in various shapes. Specifically, the pad portion 240G may be formed to correspond to the shape of the portion where the alveolar bone is removed. For example, the pad portion 240G may have a rectangular pillar shape, and may be variously formed, such as a cone or an elliptical pad.
상기와 같은 패드부(240G)는 상기 골 이식재를 바디부(210G)에 동결 건조하여 제조할 수 있다. 특히 패드부(240G)는 바디부(210G)의 일면에 미리 결정된 두께 및 면적으로 도포될 수 있다. 이때, 패드부(240G)의 두께 및 면적은 상기 치조골의 결손 정도, 발치에 따른 상기 치조골의 변형 등에 따라 결정될 수 있다. The pad portion 240G as described above may be manufactured by freeze-drying the bone graft material on the body portion 210G. In particular, the pad portion 240G may be applied to one surface of the body portion 210G in a predetermined thickness and area. At this time, the thickness and area of the pad portion 240G may be determined according to the degree of deficiency of the alveolar bone, deformation of the alveolar bone due to extraction.
따라서 임플란트용 차폐막(200G)은 상기 골 이식재를 패드 형으로 바디부(210G)에 설치하여 사용함으로써 사용상의 편의성을 증대시킬 수 있다. 뿐만 아니라 임플란트용 차폐막(200G)은 골 성분으로 형성됨으로써 시술 후 상기 치조골을 보강할 뿐만 아니라 상기 골 이식재의 경화시 상기 골 이식재의 형태가 가변하는 것을 방지할 수 있다.Therefore, the implant shield (200G) can increase the ease of use by installing the bone graft material to the body portion 210G in a pad form. In addition, the implant shield 200G may be formed of a bone component to reinforce the alveolar bone after the procedure, and to prevent the shape of the bone graft from varying when the bone graft is cured.
도 14는 본 발명의 또 다른 실시예에 따른 임플란트용 차폐막(200H)의 사시도이다.14 is a perspective view of an implant shield (200H) according to another embodiment of the present invention.
도 14를 참고하면, 임플란트용 차폐막(200H)은 바디부(210H) 및 돌출부(220H)를 포함할 수 있다. 바디부(210H)는 커버부(211H)와 절곡부(미표기)를 구비할 수 있다. 이때, 바디부(210H)는 상기 도 4 내지 도 10에 도시된 것과 동일 또는 유사하게 형성될 수 있다. 또한, 바디부(210H)는 상기에 한정되지 않으며, 골 이식재(미도시)의 형상을 유지할 수 있는 모든 형상을 포함할 수 있다. 다만, 이하에서는 설명의 편의를 위하여 바디부(210H)가 상기 도 4의 (a)에 도시된 것과 동일 또는 유사하게 형성되는 경우를 중심으로 상세히 설명하기로 한다. Referring to FIG. 14, the implantation shield 200H may include a body 210H and a protrusion 220H. The body portion 210H may include a cover portion 211H and a bent portion (not shown). In this case, the body portion 210H may be formed the same as or similar to that shown in FIGS. 4 to 10. In addition, the body portion 210H is not limited to the above, and may include any shape capable of maintaining the shape of the bone graft material (not shown). However, hereinafter, the body portion 210H will be described in detail with reference to a case in which the body portion 210H is formed the same as or similar to that shown in FIG.
특히 상기와 같은 바디부(210H)는 커버부(211H), 제1 절곡부(212H) 및 제2 절곡부(213H)를 구비할 수 있다. 이때, 제1 절곡부(212H) 및 제2 절곡부(213H)는 커버부(211H)로부터 연장되어 형성되며, 커버부(211H)로부터 절곡되어 형성될 수 있다. In particular, the body portion 210H as described above may include a cover portion 211H, a first bent portion 212H, and a second bent portion 213H. In this case, the first bent part 212H and the second bent part 213H may be formed to extend from the cover part 211H and be bent from the cover part 211H.
한편, 상기와 같은 바디부(210H)는 바디부(210H)를 관통하도록 통공(280H)이 형성될 수 있다. 이때, 통공(280H)은 바디부(210H)의 일부 영역에만 형성될 수 있다. 예를 들면, 통공(280H)은 커버부(211H)에만 형성될 수 있으며, 제1 절곡부(212H) 또는 제2 절곡부(213H)에만 형성될 수 있다. 또한, 통공(280H)은 커버부(211H)와 제1 절곡부(212H)에만 형성될 수 있으며, 제2 절곡부(213H)의 일부 영역에만 형성되는 것도 가능하다. 다만, 이하에서는 설명의 편의를 위하여 통공(280H)이 제1 절곡부(212H)에만 형성되는 경우를 중심으로 상세히 설명하기로 한다. On the other hand, the body portion 210H as described above may be formed through the hole 280H to penetrate the body portion 210H. In this case, the through hole 280H may be formed only in a partial region of the body portion 210H. For example, the through hole 280H may be formed only in the cover portion 211H, and may be formed only in the first bent portion 212H or the second bent portion 213H. In addition, the through hole 280H may be formed only in the cover portion 211H and the first bent portion 212H, or may be formed only in a partial region of the second bent portion 213H. However, hereinafter, for convenience of description, the through hole 280H will be described in detail with reference to a case where only the first bent portion 212H is formed.
상기와 같은 통공(280H)은 복수개 구비될 수 있다. 이때, 복수개의 통공(280H)의 지름은 동일하거나 서로 상이하게 형성될 수 있다. 예를 들면, 복수개의 통공(280H) 중 제1 절곡부(211H) 중앙 부분에 형성되는 통공(280H)의 지름은 다른 부분의 통공(280H)의 지름보다 크게 형성될 수 있다. 또한, 제1 절곡부(280H)의 중앙 부분을 중심으로 제1 절곡부(212H)의 외곽으로 갈수록 통공(280H)의 지름은 순차적으로 작아지도록 형성되는 것도 가능하다. A plurality of through holes 280H as described above may be provided. In this case, the diameters of the plurality of through holes 280H may be the same or different from each other. For example, the diameter of the through hole 280H formed at the center of the first bent portion 211H among the plurality of through holes 280H may be larger than the diameter of the through hole 280H of the other portion. In addition, the diameter of the through hole 280H may be formed to gradually decrease toward the outside of the first bent portion 212H around the center portion of the first bent portion 280H.
통공(280H)의 지름은 절곡부(280H)의 중앙 부분이 다른 부분보다 작게 형성되는 것도 가능하다. 또한, 통공(280H)의 지름 골 이식재(미도시)가 가장 많이 밀집한 부분이 다른 부분보다 크게 형성될 수 있다. 다만, 이하에서는 설명의 편의를 위하여 복수개의 통공(280H)의 지름이 서로 동일한 경우를 중심으로 상세히 설명하기로 한다. The diameter of the through hole 280H may be smaller than the center portion of the bent portion 280H. In addition, the most dense portion of the diameter bone graft material (not shown) of the through hole 280H may be formed larger than other portions. However, hereinafter, the diameter of the plurality of through holes 280H will be described in detail with reference to the same case for convenience of description.
상기와 같은 바디부(210H)는 혈액이나 골 성장 인자 등을 일부 통과시키나 양이 아주 적을 수 있다. 이때, 복수의 통공(280H)은 치은(미도시)으로부터 혈액이나 골 성장 인자 등이 임플란트용 차폐막(200H) 안쪽의 골 이식재(미도시)에 공급하는 통로 역할을 할 수 있다. 특히 복수개의 통공(280H)을 통하여 이동하는 혈액이나 골 성장 인자 등으로 인하여 상기 골 이식재가 치조골(미도시)에 원활하게 재생되게 할 수 있다.The body portion 210H as described above is partially passed through the blood or bone growth factors, but the amount may be very small. In this case, the plurality of through holes 280H may serve as a passage for supplying blood or bone growth factors from the gingiva (not shown) to the bone graft material (not shown) inside the implantation shield 200H. In particular, the bone graft material may be smoothly regenerated in the alveolar bone (not shown) due to blood or bone growth factors, which are moved through the plurality of through holes 280H.
따라서 임플란트용 차폐막(200H)은 골 성분으로 형성됨으로써 시술 후 상기 치조골을 보강할 뿐만 아니라 상기 골 이식재의 경화시 상기 골 이식재의 형태가 가변하는 것을 방지할 수 있다. Therefore, the implant shield (200H) is formed of a bone component can not only reinforce the alveolar bone after the procedure, but also prevent the shape of the bone graft material from varying when the bone graft material is cured.
이상에서는 본 발명의 바람직한 실시예에 대하여 도시하고 설명하였지만, 본 발명은 상술한 특정의 실시예에 한정되지 아니하며, 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자에 의해 다양한 변형실시가 가능한 것은 물론이고, 이러한 변형실시들은 본 발명의 기술적 사상이나 전망으로부터 개별적으로 이해되어서는 안 될 것이다.While the above has been shown and described with respect to preferred embodiments of the present invention, the present invention is not limited to the specific embodiments described above, it is usually in the technical field to which the invention belongs without departing from the spirit of the invention claimed in the claims. Various modifications can be made by those skilled in the art, and these modifications should not be individually understood from the technical spirit or the prospect of the present invention.

Claims (13)

  1. 치조골에 결합된 임플란트 포스트 및 상기 치조골 주위에 골재생 유도술을 위하여 첨가되는 골 이식재를 덮는 바디부를 포함하는 임플란트용 차폐막에 있어서,In the implant membrane comprising an implant post coupled to the alveolar bone and a body portion covering the bone graft material added for induction of bone regeneration around the alveolar bone,
    상기 바디부는 골 성분으로 형성되는 임플란트용 차폐막.The body portion is an implant shield membrane formed of a bone component.
  2. 제 1 항에 있어서,The method of claim 1,
    상기 바디부는 일측으로 구부러지도록 형성된 적어도 하나의 절곡부;를 포함하는 임플란트용 차폐막.And at least one bent portion formed to be bent to one side of the body portion.
  3. 제 1 항에 있어서,The method of claim 1,
    상기 골 성분으로 형성되는 상기 바디부는 이종골 또는 합성골인 임플란트용 차폐막.The body portion formed of the bone component is a distal bone or synthetic bone shield for implants.
  4. 제 3 항에 있어서,The method of claim 3, wherein
    상기 바디부는 상기 이종골을 절삭 가공하여 형성되는 임플란트용 차폐막.The body portion is an implant shielding film formed by cutting the distal bone.
  5. 제 1 항에 있어서,The method of claim 1,
    상기 바디부는 내부에 공간이 형성되며, 상기 공간의 개구부를 통하여 상기 임플란트 포스트 및 상기 골 이식재 중 적어도 하나가 삽입되도록 설치되는 임플란트용 차폐막.The body portion has a space formed therein, the implant shield is installed so that at least one of the implant post and the bone graft material is inserted through the opening of the space.
  6. 제 1 항에 있어서,The method of claim 1,
    상기 바디부로부터 돌출되어 형성되는 돌출부;를 더 포함하는 임플란트용 차폐막.The shielding membrane for an implant further comprising a protrusion formed to protrude from the body portion.
  7. 제 6 항에 있어서,The method of claim 6,
    상기 돌출부는, 상기 임플란트 포스트의 상부면에 형성된 치관 결합용 암나사부 또는 상기 치관 결합용 암나사부에 체결되는 임시볼트의 상부면에 형성된 형성된 오목부에 억지끼움 결합되는 임플란트용 차폐막.The protruding portion is an implant shielding film coupled to the concave portion formed on the upper surface of the temporary bolt fastened to the female screw portion or the crown coupling female screw portion formed on the upper surface of the implant post.
  8. 제 1 항에 있어서,The method of claim 1,
    상기 골 이식재로 형성되며, 상기 바디부에 패드 형태로 부착되는 패드부;를 더 포함하는 임플란트용 차폐막.A shielding membrane for an implant further comprising a pad portion formed of the bone graft material and attached to the body portion in a pad form.
  9. 제 1 항에 있어서,The method of claim 1,
    상기 바디부는 표면에는 관통하도록 통공이 형성되는 임플란트용 차폐막.Implant shielding film is formed through the body portion to penetrate the surface.
  10. 제 9 항에 있어서,The method of claim 9,
    상기 통공은 복수개 구비되며,The through hole is provided with a plurality,
    상기 복수개의 통공은 지름이 서로 상이한 임플란트용 차폐막.The plurality of through-holes are shielding membrane for implants different diameters.
  11. 제 9 항에 있어서,The method of claim 9,
    상기 통공은 상기 바디부의 일부 영역에만 형성되는 임플란트용 차폐막.The through-holes are shielding membrane for the implant is formed only in a portion of the body portion.
  12. 제 1 항에 있어서,The method of claim 1,
    상기 바디부는, 상기 치조골 및 상기 골 이식재 중 적어도 하나와 상기 바디부를 고정시키는 고정부재가 결합하는 고정부재결합부;를 구비하는 임플란트용 차폐막.The body portion, a shield member for an implant comprising a; fixing member coupling portion is coupled to the fixing member for fixing the body portion and at least one of the alveolar bone and the bone graft.
  13. 제 1 항에 있어서,The method of claim 1,
    상기 바디부의 적어도 일면은 치열에 대응되는 곡률반경을 갖는 곡면으로 형성되는 임플란트용 차폐막.At least one surface of the body portion implant shielding film formed of a curved surface having a radius of curvature corresponding to the teeth.
PCT/KR2014/003889 2014-04-30 2014-04-30 Barrier membrane for implant WO2015167050A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2014/003889 WO2015167050A1 (en) 2014-04-30 2014-04-30 Barrier membrane for implant
CN201480078246.9A CN106232051A (en) 2014-04-30 2014-04-30 Dental Implant barrier film

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2014/003889 WO2015167050A1 (en) 2014-04-30 2014-04-30 Barrier membrane for implant

Publications (1)

Publication Number Publication Date
WO2015167050A1 true WO2015167050A1 (en) 2015-11-05

Family

ID=54358767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/003889 WO2015167050A1 (en) 2014-04-30 2014-04-30 Barrier membrane for implant

Country Status (2)

Country Link
CN (1) CN106232051A (en)
WO (1) WO2015167050A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018064919A1 (en) * 2016-10-06 2018-04-12 高雄医学大学 Intraosseous implant and preparation method therefor
CN109646714A (en) * 2019-01-15 2019-04-19 上海交通大学医学院附属第九人民医院 A kind of 3 D-printing titanium net implants with osteogenic induction coating
US11872105B1 (en) 2022-12-01 2024-01-16 Robert Parker Dental implant device for regeneration of dental pulp and dentin
US11931224B1 (en) 2022-12-19 2024-03-19 Robert Parker Tooth pod

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107260340A (en) * 2017-05-31 2017-10-20 司家文 The protection structure of Alveolar Bone Defect bone graft area
CN108904881A (en) * 2018-10-11 2018-11-30 泰山医学院 Racemic polylactic acid intersects reinforcement type biodegradability barrier film and preparation method thereof with magnesium net
CN109620429B (en) * 2018-12-03 2020-09-25 北京航空航天大学 Degradable metal-guided tissue regeneration barrier membrane and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070088477A (en) * 2005-12-16 2007-08-29 히데사토 하라 Dental material and composite dental material formed by using hydroxy apatite
KR20110113587A (en) * 2010-04-09 2011-10-17 서울대학교산학협력단 Biopolymer/silica xerogel hybrid membrane modified by bioactive factors for guided tissue regeneration and method thereof
KR101182806B1 (en) * 2012-08-20 2012-09-13 오스템임플란트 주식회사 Membrane for bone-repair
KR101213244B1 (en) * 2011-06-28 2012-12-18 연세대학교 산학협력단 Combination of bone graft material and a barrier membrane and manufacturing method thereof
KR20130004371U (en) * 2012-01-05 2013-07-15 주식회사 제일메디칼코퍼레이션 Membrane for dental implant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0618930D0 (en) * 2006-09-26 2006-11-08 Smith & Nephew Medical implant
WO2013019007A2 (en) * 2011-07-29 2013-02-07 오스템임플란트 주식회사 Membrane for alveolar bone regeneration
CN102499768B (en) * 2011-10-27 2013-12-04 施生根 Mucoperiosteal type implant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070088477A (en) * 2005-12-16 2007-08-29 히데사토 하라 Dental material and composite dental material formed by using hydroxy apatite
KR20110113587A (en) * 2010-04-09 2011-10-17 서울대학교산학협력단 Biopolymer/silica xerogel hybrid membrane modified by bioactive factors for guided tissue regeneration and method thereof
KR101213244B1 (en) * 2011-06-28 2012-12-18 연세대학교 산학협력단 Combination of bone graft material and a barrier membrane and manufacturing method thereof
KR20130004371U (en) * 2012-01-05 2013-07-15 주식회사 제일메디칼코퍼레이션 Membrane for dental implant
KR101182806B1 (en) * 2012-08-20 2012-09-13 오스템임플란트 주식회사 Membrane for bone-repair

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018064919A1 (en) * 2016-10-06 2018-04-12 高雄医学大学 Intraosseous implant and preparation method therefor
CN109646714A (en) * 2019-01-15 2019-04-19 上海交通大学医学院附属第九人民医院 A kind of 3 D-printing titanium net implants with osteogenic induction coating
US11872105B1 (en) 2022-12-01 2024-01-16 Robert Parker Dental implant device for regeneration of dental pulp and dentin
US11931224B1 (en) 2022-12-19 2024-03-19 Robert Parker Tooth pod

Also Published As

Publication number Publication date
CN106232051A (en) 2016-12-14

Similar Documents

Publication Publication Date Title
WO2015167050A1 (en) Barrier membrane for implant
KR20140128889A (en) Membrane for implant operation
US6712851B1 (en) Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5919234A (en) Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
Visser et al. Fate of implant-retained craniofacial prostheses: life span and aftercare.
WO2015133698A1 (en) Dental implant fixture capable of easily receiving blood
AU761058B2 (en) Membrane with tissue-guiding surface corrugations
CA2511785C (en) Improvements in components for permanent removable and adjustable dentures and bridges
US20080081315A1 (en) Dr. Seoung Ho Lee's augmentation plates for stabilizing dental implant fixtures
PL206534B1 (en) Implant for implanting in bone tissue or in bone tissue supplemented with bone substitute material
CA2873225C (en) Dental devices for extraction site reconstruction
WO2013151258A1 (en) Denture-fixing attachment having freely adjustable angle and position
WO2018026194A1 (en) Barrier membrane for dental procedure
KR200456270Y1 (en) Fixture for implant
WO2017105057A1 (en) Integrated dental hybrid implant
WO2018026193A1 (en) Barrier membrane for dental procedure
WO2019240478A1 (en) Implant comprising biodegradable material
KR20120116412A (en) Implants and methods for performing gums and bone augmentation and preservation
WO2015012430A1 (en) Healing abutment capable of obtaining impression
WO2024101837A1 (en) Dental healing abutment
WO2012074144A1 (en) Implant device having firm fastening structure between abutment and zirconia cap
WO2023085641A1 (en) Implant having multiple support structure
WO2017010811A1 (en) Personalized alveolar bone tissue and method for manufacturing same
WO2015167049A1 (en) Barrier membrane for implant
EA022319B1 (en) Dental implant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14890702

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14890702

Country of ref document: EP

Kind code of ref document: A1